Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE006499 |
YEM_ID: | YEM-675 |
ID: | TCMBANKHE006499/YEM-675 |
植物拉丁名: |
|
功能与主治: | To dispel cold from the stomach, and to eliminate phlegm./Vomiting with stomach cold, abdominal pain and diarrhea, inappetence, convulsion, epilepsy and profuse phlegm. |
药用植物名: | 胡椒 |
药名: | 胡椒 |
来源: | 云南民族药物志：第四卷 |
药用部位: | fruit |
使用民族: | 傣族/回族/傈僳族/佤族/彝族/藏族 |
药味: | Hot; Pungent |
经络: | Large Intestine; Stomach |
临床特征: | 1. Increasing secretion of digestive and promoting gastrointestinal peristalsis by oral administration.2. Piperine is an antipyretic and wind-expelling agent. |
治疗类型: | 温里药 |
TCM_ID_id: | 1970 |
SymMap_id: | 173 |
TCMSP_id: | 348 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000095 | oxymatrine | Ammothamnine; STOCK1N-33797 | C15H24N2O2 | 264.36 | C1CC2C3CCC[N+]4(C3C(CCC4)CN2C(=O)C1)[O-] |
| TCMBANKIN000100 | lauric acid | NCGC00090919-01; CHEBI:30805; n-Dodecanoic acid; Hydrofol acid 1255; Wecoline 1295; Neo-Fat 12-43; 8045-27-0; WLN: QV11; AI3-00112; AIDS-049202; 61609_FLUKA; Dodecylcarboxylate; DAO; EINECS 205-582-1; L-ALFA-LYSOPHOSPHATIDYLCHOLINE, LAUROYL; CCRIS 669; W261408_ALDRICH; lauric acid ; 8000-62-2; DODECANOIC ACID (LAURIC ACID); C-1297; 7632-48-6; ST023796; NSC5026; Laurinsaeure; C02679; [2-((1-OXODODECANOXY-(2-HYDROXY-3-PROPANYL))-PHOSPHONATE-OXY)-ETHYL]-TRIMETHYLAMMONIUM; Dodecoic acid; Laurostearic acid; NCGC00090919-02; 4-02-00-01082 (Beilstein Handbook Reference); lauricacid; Ninol AA62 extra; InChI=1/C12H24O2/c1-2-3-4-5-6-7-8-9-10-11-12(13)14/h2-11H2,1H3,(H,13,14; Lauric acid (natural); Aliphat No. 4; NSC-5026; Coconut oil fatty acids; Lauric acid, pure; 203714-07-2; NCIOpen2_009480; CH3-[CH2]10-COOH; Dodecylic acid; Neo-Fat 12; AIDS049202; C12 fatty acid; HSDB 6814; Dodecanoic acid; L556_ALDRICH; Lauric acid; LAP; Univol U-314; FEMA No. 2614; 1-Undecanecarboxylic acid; Vulvic acid; 143-07-7; BRN 1099477; Duodecylic acid; LAU; W261416_ALDRICH; LMFA01010012; L4250_SIGMA; Hydrofol acid 1295 | C12H24O2 | 200.32 | CCCCCCCCCCCC(=O)O |
| TCMBANKIN000288 | (1R,2R,4R)-Dihydrocarveol | (1R,2R,5R)-5-Isopropenyl-2-methylcyclohexanol; LMPR01020079; (1R,2R,5R)-2-methyl-5-prop-1-en-2-ylcyclohexan-1-ol; (1R,2R,5R)-5-isopropenyl-2-methyl-1-cyclohexanol; (−)-Dihydrocarveol; C11396; (1R,2R,5R)-5-isopropenyl-2-methyl-cyclohexan-1-ol; 37278_FLUKA; (1R,2R,5R)-2-methyl-5-prop-1-en-2-yl-cyclohexan-1-ol | C10H18O | 154.25 | CC1CCC(CC1O)C(=C)C |
| TCMBANKIN000536 | Trichostachine | ACon1_000155; 5-(1,3-benzodioxol-5-yl)-1-pyrrolidin-1-ylpenta-2,4-dien-1-one; 25924-78-1; Pyrrolidine, 1-[5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]-, (E,E)-; trichostachine; MEGxp0_000203; 54976-54-4; 5-(1,3-benzodioxol-5-yl)-1-pyrrolidin-1-yl-penta-2,4-dien-1-one; Pyrrolidine, 1-piperoyl-, (E,E)-; 5-(1,3-benzodioxol-5-yl)-1-1-pyrrolidinylpenta-2,4-dien-1-one; Pyrrolidine, 1-(5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)-; C10174; 1-(5-(1,3-Benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)pyrrolidine; (2E,4E)-5-(1,3-benzodioxol-5-yl)-1-1-pyrrolidinylpenta-2,4-dien-1-one; (2E,4E)-5-(1,3-benzodioxol-5-yl)-1-pyrrolidin-1-yl-penta-2,4-dien-1-one; (2E,4E)-5-(1,3-benzodioxol-5-yl)-1-pyrrolidin-1-ylpenta-2,4-dien-1-one | C16H17NO3 | 271.31 | C1CCN(C1)C(=O)C=CC=CC2=CC3=C(C=C2)OCO3 |
| TCMBANKIN001063 | Ethylcinnamate | (E)-3-phenylacrylic acid ethyl ester; AI3-00667; W243019_ALDRICH; Ethyl cinnamate (natural); 112372_ALDRICH; Ethyl 3-phenyl-2-propenoate; NSC6773; FEMA No. 2430; Ethyl (2E)-3-phenyl-2-propenoate; ?ethylcinnamate ; Ethylcinnamoate; ethyl cinnamate; ethylcinnamate; Ethyl cinnamate; InChI=1/C11H12O2/c1-2-13-11(12)9-8-10-6-4-3-5-7-10/h3-9H,2H2,1H3/b9-8; 2-Propenoic acid, 3-phenyl-, ethyl ester, (E)-; BRN 1238804; EINECS 203-104-6; AIDS224200; NSC 6773; 2-Propenoic acid, 3-phenyl-, ethyl ester; Ethyl trans-cinnamate; Ethyl 3-phenylpropenoate; Cinnamic acid, ethyl ester; ethyl (2E)-3-phenylacrylate; Ethyl benzylideneacetate; WLN: 2OV1U1R; 3-Phenyl-2-propenoic acid, ethyl ester; Ethyl 3-phenylacrylate; ethyl (E)-3-phenylprop-2-enoate; CINNAMIC ACID,ETHYL ESTER; Cinnamic acid ethyl ester; W243000_ALDRICH; ethyl 3-phenylprop-2-enoate; 96350_FLUKA; C06359; 3-Phenyl-acrylic acid, ethyl ester; Ethyl beta-phenylacrylate; AIDS-224200; (E)-3-phenylprop-2-enoic acid ethyl ester; ZINC00896133; 3-phenylacrylic acid ethyl ester; 103-36-6; 3-phenylprop-2-enoic acid ethyl ester | C11H12O2 | 176.21 | CCOC(=O)C=CC1=CC=CC=C1 |
| TCMBANKIN001738 | l-alpha-Fenchone | 11000-29-6; (1R,4S)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-one; 7787-20-4; EINECS 232-107-5; (1R,4S)-1,3,3-trimethylnorbornan-2-one; (1R,4S)-fenchan-2-one; CHEBI:36612; Bicyclo(2.2.1)heptan-2-one, 1,3,3-trimethyl-, (1theta)-; 1,3,3-Trimethylnorbornan-2-one; (1R,4S)-fenchone; InChI=1/C10H16O/c1-9(2)7-4-5-10(3,6-7)8(9)11/h7H,4-6H2,1-3H; (1R,4S)-1,3,3-trimethyl-2-norbornanone; Bicyclo(2.2.1)heptan-2-one, 1,3,3-trimethyl-, (1R,4S)-; L-alpha-Fenchone; ZINC00967570 | C10H16O | 152.23 | CC1(C2CCC(C2)(C1=O)C)C |
| TCMBANKIN001874 | 1(7),2-p-menthadien-4-ol | 1-ISOPROPYL-4-METHYLIDENECYCLOHEX-2-EN-1-OL; 4-methylidene-1-propan-2-ylcyclohex-2-en-1-ol; xi-p-Mentha-1(7),2-dien-4-ol; AC1NSXYJ; 4-methylidene-1-(propan-2-yl)cyclohex-2-en-1-ol; p-Mentha-1(7),2-diene-4-ol | C10H16O | 152.23 g/mol | CC(C)C1(CCC(=C)C=C1)O |
| TCMBANKIN002813 | 1-(1-oxo-2 e-decaenyl) piperidine | 1-(1-oxo-2e-decaenyl)piperidine | CCCCCCCC=CC(=O)N1CCCCC1 | ||
| TCMBANKIN003867 | cis-Piplartine | 1-[3-(3,4,5-Trimethoxy-phenyl)-acryloyl]-5,6-dihydro-1H-pyridin-2-one; CAS-20069-09-4; 1-[(Z)-3-(3,4,5-trimethoxyphenyl)acryloyl]-5,6-dihydropyridin-2-one; 1-[(Z)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]-5,6-dihydropyridin-2-one; NCGC00016746-01; 1-[(Z)-1-oxo-3-(3,4,5-trimethoxyphenyl)prop-2-enyl]-5,6-dihydropyridin-2-one; 1-[(2Z)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]-5,6-dihydropyridin-2(1H)-one; InChI=1/C17H19NO5/c1-21-13-10-12(11-14(22-2)17(13)23-3)7-8-16(20)18-9-5-4-6-15(18)19/h4,6-8,10-11H,5,9H2,1-3H3/b8-7; 8(Z)-N-(12,13,14-Trimethoxycinnamoyl)-Delta3-pyridin-2-one; 2(1H)-pyridinone, 5,6-dihydro-1-[(2Z)-1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl]- | C17H19NO5 | 317.34 | COC1=CC(=CC(=C1OC)OC)C=CC(=O)N2CCC=CC2=O |
| TCMBANKIN006130 | cis-p-2-menthen- 1-ol | 4beta-tert-Butyl-2-cyclohexen-1beta-ol; (1R,4S)-4-tert-butyl-1-cyclohex-2-enol; (1R,4R)-1-methyl-4-propan-2-yl-cyclohex-2-en-1-ol; 2-Cyclohexen-1-ol, 1-methyl-4-(1-methylethyl)-, (1R,4R)-rel-; (1R,4R)-4-isopropyl-1-methyl-cyclohex-2-en-1-ol; cis-1-Methyl-4-(1-methylethyl)-2-cyclohexen-1-ol; (1R,4R)-1-methyl-4-propan-2-ylcyclohex-2-en-1-ol; cis-p-2-menthen-1-ol; (1R,4R)-4-isopropyl-1-methyl-1-cyclohex-2-enol; 2-Cyclohexen-1-ol, 1-methyl-4-(1-methylethyl)-, cis-; cis-p-2-Menthen-1-ol; cis-4-(Isopropyl)-1-methylcyclohex-2-en-1-ol; EINECS 249-860-0; AC1O5388; (1R,4S)-4-tert-butylcyclohex-2-en-1-ol; NGXNAIZTJAUMGV-BDAKNGLRSA-N; 29803-82-5 | C10H18O | 154.25 g/mol | CC(C)C1CCC(C=C1)(C)O |
| TCMBANKIN007637 | (1S,5S)-1-isopropyl-4-methylenebicyclo[3.1.0]hexane | (1S,5S)-1-isopropyl-4-methylene-bicyclo[3.1.0]hexane; (1S,5S)-4-methylidene-1-propan-2-ylbicyclo[3.1.0]hexane; (1S,5S)-4-methylidene-1-propan-2-yl-bicyclo[3.1.0]hexane | C10H16 | 136.23 g/mol | CC(C)C12CCC(=C)C1C2 |
| TCMBANKIN009958 | (1R)-4-isopropenyl-1-methyl-1-cyclohex-3-enol | 3,8(9)-p-Menthadien-1-ol; (1R)-4-isopropenyl-1-methyl-cyclohex-3-en-1-ol; (1R)-1-methyl-4-prop-1-en-2-yl-cyclohex-3-en-1-ol; (1R)-1-methyl-4-prop-1-en-2-ylcyclohex-3-en-1-ol | 152.26 | ||
| TCMBANKIN010750 | 5,10b- epoxy- phenanthridine | C18H19NO6 | COC1CC2C3(C4C1O4)C(=O)CN2CC5=C(C6=C(C=C35)OCO6)OC | ||
| TCMBANKIN011319 | germacrene | germacrene d; Germacrene-D | C15H24 | 204.35 | CC1=CCCC(=CCC(CC1)C(=C)C)C |
| TCMBANKIN011605 | N-Isobutyl-2,4-icosadienamide | N-Isobutyl-2,4-eicosadienamide; (2E,4E)-N-(2-methylpropyl)icosa-2,4-dienamide; (2E,4E)-N-isobutylicosa-2,4-dienamide; 2,4-Eicosadienamide, N-(2-methylpropyl)-, (E,E)-; 54794-71-7 | C24H45NO | 363.62 | CCCCCCCCCCCCCCCC=CC=CC(=O)NCC(C)C |
| TCMBANKIN012312 | (E)-7-(1,3-benzodioxol-5-yl)-1-piperidino-hept-6-en-1-one | (E)-7-(1,3-benzodioxol-5-yl)-1-(1-piperidyl)hept-6-en-1-one; (E)-7-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylhept-6-en-1-one; (E)-7-(1,3-benzodioxol-5-yl)-1-piperidin-1-yl-hept-6-en-1-one | C19H21NO3 | 311.37 | |
| TCMBANKIN012545 | 4,5-DIHYDROXY-N-(2-METHYLPROPYL)DEC-2-ENAMIDE | C14H27NO3 | CCCCCC(C(C=CC(=O)NCC(C)C)O)O | ||
| TCMBANKIN012731 | 1-(2-methoxypropan-2-yl)-4-methylbenzene | 1-(1-methoxy-1-methyl-ethyl)-4-methyl-benzene; 1-(2-methoxypropan-2-yl)-4-methyl-benzene; 1-(1-methoxy-1-methylethyl)-4-methylbenzene | C11H16O | 164.24 | CC1=CC=C(C=C1)C(C)(C)OC |
| TCMBANKIN013005 | (1S,3R,5S)-6,6-dimethyl-2-methylene-3-norpinanol | SMP2_000270; (1S,3R,5S)-7,7-dimethyl-4-methylidene-bicyclo[3.1.1]heptan-3-ol; (1S,3R,5S)-6,6-dimethyl-2-methylene-norpinan-3-ol; STOCK1N-51374; (1S,3R,5S)-7,7-dimethyl-4-methylidenebicyclo[3.1.1]heptan-3-ol; ZINC00968034 | C10H16O | 152.23 | CC1(C2CC1C(=C)C(C2)O)C |
| TCMBANKIN013310 | Piperitylhonokiol | AC1NSZON; 2-(4-hydroxy-3-prop-2-enylphenyl)-6-(3-methyl-6-propan-2-ylcyclohex-2-en-1-yl)-4-prop-2-enylphenol; piperitylhonokiol | C28H34O2 | 402.6 g/mol | CC1=CC(C(CC1)C(C)C)C2=CC(=CC(=C2O)C3=CC(=C(C=C3)O)CC=C)CC=C |
| TCMBANKIN014175 | Piperitenone | NCI60_023460; 3-methyl-6-propan-2-ylidene-cyclohex-2-en-1-one; LMPR0102090056; p-Menth-1,4(8)-dien-3-one; CHEMBL54161; UNII-IKR841W74D; 3-Methyl-6-(1-methylethylidene)-2-cyclohexen-1-one #; NSC-667470; CHEBI:17304; ZINC18157343; IKR841W74D; AIDS-161030; Pulespenone; FEMA No. 3560; 6-isopropylidene-3-methyl-cyclohex-2-en-1-one; p-Mentha-1,4(8)-dien-3-one; 2-Cyclohexen-1-one,3-methyl-6-(1-methylethylidene)-; SCHEMBL220677; 1-Methyl-4-isopropylidene-1-cyclohexen-3-one; NSC667470; AC1Q6A92; FEMA 3560; AK546262; 3-Methyl-6-(propan-2-ylidene)cyclohex-2-enone; 3-methyl-6-propan-2-ylidenecyclohex-2-en-1-one; AIDS161030; 3-Methyl-6-(1-methylethylidene)-2-cyclohexen-1-one; 2-CYCLOHEXEN-1-ONE, 3-METHYL-6-(1-METHYLETHYLIDENE)-; 3-Methyl-6-(1-methylethylidene)-2-cyclohexen-1-one, 9CI; HKZQJZIFODOLFR-UHFFFAOYSA-N; AKOS022504705; 3-methyl-6-(propan-2-ylidene)cyclohex-2-en-1-one; HKZQJZIFODOLFR-UHFFFAOYSA-; 6-isopropylidene-3-methyl-1-cyclohex-2-enone; MolPort-001-787-631; Z2492396266; piperitenone; EINECS 207-729-5; InChI=1/C10H14O/c1-7(2)9-5-4-8(3)6-10(9)11/h6H,4-5H2,1-3H3; C01951; AC1L8GSJ; 6-Isopropylidene-3-methyl-2-cyclohexenone; 3-Methyl-6-(1-methylethylidene)cyclohex-2-en-1-one; 3-Terpinolenone; 491-09-8 | C10H14O | 150.22 | CC1=CC(=O)C(=C(C)C)CC1 |
| TCMBANKIN014213 | 21987_FLUKA | (1S,3R)-cis-4-Carene; (1R,4R)-4,7,7-Trimethylbicyclo[4.1.0]hept-2-ene; (1S,3R,6R)-3,7,7-trimethylbicyclo[4.1.0]hept-4-ene | C10H16 | 136.23 | CC1CC2C(C2(C)C)C=C1 |
| TCMBANKIN015163 | 2-[(1R)-4-methyl-1-cyclohex-3-enyl]prop-2-enyl acetate | acetic acid 2-[(1R)-4-methyl-1-cyclohex-3-enyl]prop-2-enyl ester; 2-[(1R)-4-methyl-1-cyclohex-3-enyl]prop-2-enyl ethanoate | C12H18O2 | 194.27 | |
| TCMBANKIN015220 | (6R)-6-isopropyl-3-methyl-1-cyclohex-2-enone | 2-Cyclohexen-1-one, 3-methyl-6-(1-methylethyl)-, (6R)-; (R)-6-(Isopropyl)-3-methylcyclohex-2-en-1-one; EINECS 224-957-0; (6R)-6-isopropyl-3-methyl-cyclohex-2-en-1-one; (6R)-3-methyl-6-propan-2-ylcyclohex-2-en-1-one; 4573-50-6; (6R)-3-methyl-6-propan-2-yl-cyclohex-2-en-1-one | C10H16O | 152.23 | CC1=CC(=O)C(CC1)C(C)C |
| TCMBANKIN016693 | trans-pinocarveol | Pinocarveol, cis-(+/-)-; trans-pinocarveol ; ZINC4102279; UNII-31P964S048 component LCYXQUJDODZYIJ-HRDYMLBCSA-N; (1R,5beta)-6,6-Dimethyl-2-methylenebicyclo[3.1.1]heptan-3alpha-ol; 6712-79-4; Bicyclo(3.1.1)heptan-3-ol, 6,6-dimethyl-2-methylene-, (1R,3R,5R)-rel-; DTXSID00217419; trans- pinocarveol; Bicyclo(3.1.1)heptan-3-ol, 6,6-dimethyl-2-methylene-, (1alpha,3beta,5alpha)-; 2(10)-Pinen-3-ol, cis-; UNII-0WG2C7KI43 component LCYXQUJDODZYIJ-HRDYMLBCSA-N; trans-Pinocarveol | C10H16O | 152.23 g/mol | CC1(C2CC1C(=C)C(C2)O)C |
| TCMBANKIN016769 | (1-oxo-3-phenyl-2 e-propenyl)pyrrolidine | (1-oxo-3-phenyl-2e-propenyl)pyrrolidine | C1CCN(C1)C(=O)C=CC2=CC=CC=C2 | ||
| TCMBANKIN017682 | 3,8,9-thihydroxy-6H-benzo[c] chromen-6-one | ||||
| TCMBANKIN017988 | 1-dodecanol | AC1O5YKJ; 1-dodecenol; 58877-59-1; Dodecenol; (E)-dodec-1-en-1-ol; SCHEMBL131306; ZINC100496838; I14-102383 | C12H26O | 186.33 | CCCCCCCCCCC=CO |
| TCMBANKIN017993 | vitamin c | D01CWN; Cell C; Ronotec 100; P 1110; Suncoat VC 40; D-threo-hex-2-enoic acid gamma-lactone; Citrovit; 2-o-(beta-d-glucopyranosyl)-ascorbic acid_qt; Juvamine; SCHEMBL13468284; Vasc; CHEBI:51384; D-Lyxoascorbic acid; CHEMBL1253320; AK481251; Chewcee; D-xyloascorbic acid; C8DQ5M1Y1E; MLS001066386; AK322241; Ascorbic acid, D-; AC1LD8K5; E 300; Scorbu C; 10504-35-5; Ascorbicacid; l(+)-ascorbic acid; ZINC100006137; L-ascorbate (vitamin C); (5S)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one; (+)-Ascorbic acid; UNII-C8DQ5M1Y1E; Ascorbinsaure; Ceklin; VC 97; (2S)-2-[(1R)-1,2-bis(oxidanyl)ethyl]-4,5-bis(oxidanyl)furan-3-one; Vicin; L-ascorbate acid; L-ascorbic acid; L-dehydroascorbic acid; ascorbate; D-threo-hex-2-enono-1,4-lactone; Kangbingfeng; D-Ascorbic acid; Viscorin 100M; ZINC100028197; (2S)-2-[(1R)-1,2-dihydroxyethyl]-4,5-dihydroxy-3-furanone; L-Ascorbic acid (8CI,9CI); Proscorbin Redoxon Ribena Ronotec 100; Hex-2-enonic acid gamma-lactone, L-threo; (5S)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxy-2,5-dihydrofuran-2-one; Ascorbic acid; DL-Ascorbic acid; AKOS000278050; Cebion, gamma-lactone; F91F7DA3-A3D5-4FB4-A6E7-C497C48D192A; GTPL4651; SMR000471843; Xyloascorbic acid, L-; Rontex 100; Rovimix C; (2S)-2-[(1R)-1,2-dihydroxyethyl]-4,5-dihydroxyfuran-3-one; A828310 | C6H8O6 | 176.12 | C(C(C1C(=C(C(=O)O1)O)O)O)O |
| TCMBANKIN019008 | piperoline a,b | piperoline a, b | |||
| TCMBANKIN021789 | n-isobutyl-2 e,4 e,12z-octadecatrienamide | n-isobutyl-2e,4 e,12z-octadecatrienamide | C22H39NO | CCCCCC=CCCCCCCC=CC=CC(=O)NCC(C)C | |
| TCMBANKIN022360 | (±)-threo-n-isobutyl-4,5-dihydroxy-2 e-octaenamide | (±)-threo-n-isobutyl-4,5-dihydroxy-2e-octaenamide | C12H23NO3 | CCCC(C(C=CC(=O)NCC(C)C)O)O | |
| TCMBANKIN022423 | l-phellandrene | L- Phellandrene | |||
| TCMBANKIN022613 | 1(7),2-p-Menthadien-6-ol | 3-Cyclohexen-1-ol, 2-methylene-5-(1-methylethyl)-, trans-; 1(7),2-p-menthadien-6-ol; 3-Cyclohexen-1-ol, 2-methylene-5-(1-methylethyl)-, (1S-trans)- (9CI); 95259-30-6; 114179-04-3; (1S,5R)-5-ISOPROPYL-2-METHYLIDENECYCLOHEX-3-EN-1-OL; VKAGFXRPRUAOHV-ZJUUUORDSA-N; CTK3F4020 | C10H16O | 152.23 | CC(C)C1CC(C(=C)C=C1)O |
| TCMBANKIN026267 | NFP | NSC 404158; Piperidinoformamide; piperidine-1-carbaldehyde; EINECS 219-986-0; ZINC00388699; NSC1066; AI3-15238; NSC 1066; FPI; WLN: T6NTJ AVH; N-Formylpiperidine; Formylpiperidine; N-Formylpiperidin; Piperidine-1-carboxaldehyde; F17407_ALDRICH; 2591-86-8; N-Formylpiperidin [German]; Piperidine-N-carbaldehyde; NSC404158; SBB004316; Piperidine, 1-formyl-; 1-Piperidinecarboxaldehyde; 1-Formylpiperidine; InChI=1/C6H11NO/c8-6-7-4-2-1-3-5-7/h6H,1-5H | C6H11NO | 113.16 | C1CCN(CC1)C=O |
| TCMBANKIN026703 | 1-[1-oxo-3(3,4-methylenedioxy-5-methoxy-phenyl)-2zpropenyl] piperidine | C16H19NO4 | 289.33 g/mol | COC1=CC(=CC2=C1OCO2)C=CC(=O)N3CCCCC3 | |
| TCMBANKIN026797 | -cis-.beta.-Elemene diastereomer | (1S,2R,4R)-2,4-diisopropenyl-1-methyl-1-vinyl-cyclohexane; (1S,2R,4R)-2,4-diisopropenyl-1-methyl-1-vinylcyclohexane; (1S,2R,4R)-1-ethenyl-1-methyl-2,4-di(prop-1-en-2-yl)cyclohexane | C15H24 | 204.35 | |
| TCMBANKIN027175 | 2-Phenylpropene | 2-phenyl-2-propene; WLN: 1YR & U1; NCGC00090741-01; alpha-Methylstyrene; .alpha.-Metil-stirolo; 81523_FLUKA; .alpha.-Methylstyreen; 81517_FLUKA; Isopropenil-benzolo [Italian]; .beta.-Phenylpropylene; C14395; Isopropenyl-benzol [German]; UN2303; Styrene, .alpha.-methyl-; 42612-14-6; (1-Methylethenyl)benzene; InChI=1/C9H10/c1-8(2)9-6-4-3-5-7-9/h3-7H,1H2,2H; NSC 9400; 1-Methyl-1-phenylethylene; NSC9400; alpha-Metil-stirolo [Italian]; alpha-Methylstyrene monomer; Benzene, (1-methylethenyl)-; beta-Phenylpropylene; 1-Methyl-1-phenylethene; .alpha.-Methylstyrol; EINECS 202-705-0; 81520_FLUKA; prop-1-en-2-ylbenzene; AI3-18133; Ortho Brush Killer A; alpha-Methylstyreen [Dutch]; 25014-31-7; 2-Phenylpropylene; 69170_FLUKA; Isopropenyl-benzeen [Dutch]; Isopropenylbenzene; 81516_FLUKA; HSDB 196; ghl.PD_Mitscher_leg0.286; 81524_FLUKA; alpha-Methyl-styrol [German]; LS-2049; .alpha.-Methylstyrene; .beta.-Phenylpropene; 1-Phenyl-1-methylethylene; Styrene, alpha-methyl-; Isopropenil-benzolo; Isopropenyl-benzeen; 1-Propene, 2-phenyl-; 81519_FLUKA; Isopropenyl-benzol; ALPHA-METHYL STYRENE; 81522_FLUKA; 81513_FLUKA; as-Methylphenylethylene; Poly(alpha-methylstyrene); 81514_FLUKA; 81518_FLUKA; .alpha.-Methyl-styrol; Isopropenylbenzene [UN2303] [Flammable liquid]; 98-83-9; alpha-Methylstyrol; beta-Phenylpropene; 69168_FLUKA; Benzene, (1-methylethenyl)-, homopolymer; 2-Phenyl-1-propene; 1-Methylethylenebenzene; CCRIS 6067; M80903_ALDRICH; 1-MethylethenylBenzine | C9H10 | 118.18 | CC(=C)C1=CC=CC=C1 |
| TCMBANKIN027512 | matrine | .alpha.-Matrine; Matrene, (+)-; STOCK1N-36535; Matrine; BRN 0085851; (+)-Matrine; ZINC4196454; 519-02-8; Matridin-15-one (9CI); C10774; NSC146051; 5-24-02-00301 (Beilstein Handbook Reference); NSC 146051 | C15H24N2O | 248.36 | C1CC2C3CCCN4C3C(CCC4)CN2C(=O)C1 |
| TCMBANKIN028632 | dihydrocarveol | C10H18O | 154.25 g/mol | CC1CCC(CC1O)C(=C)C | |
| TCMBANKIN028740 | 1-(1,6-dioxo-2e,4 e-decadienyl)piperidine | C15H23NO2 | CCCCC(=O)C=CC=CC(=O)N1CCCCC1 | ||
| TCMBANKIN029006 | piperonal | 1,3-benzodioxole-5-carbaldehyde; FR-0263; 3,4-Dihydroxybenzaldehyde methylene ketal; Heliotropine; CCRIS 5928; 3,4-(Methylenedioxy)benzaldehyde; NCGC00091137-01; CHEBI:8240; Geliotropin; 120-57-0; W291102_ALDRICH; 3,4-Methylene-dihydroxybenzaldehyde; C10812; 3,4-Methylenedioxybenzaldehyde; WLN: T56 BO DO CHJ GVH; Heliotropin (natural); NSC 26826; SBB007752; Piperonylaldehyde; 5-Formyl-1,3-benzodioxole; Dioxymethylene protocatechuic aldehyde; Piperonyl aldehyde; Benzaldehyde, 3,4-(methylenedioxy)-; InChI=1/C8H6O3/c9-4-6-1-2-7-8(3-6)11-5-10-7/h1-4H,5H; Piperonaldehyde; Protocatechuic aldehyde methylene ether; EINECS 204-409-7; ZINC00001953; NSC26826; FEMA No. 2911; 3,4-Dimethylenedioxybenzaldehyde; 1,3-Benzodioxole-5-carboxaldehyde; 80820_FLUKA; P49104_ALDRICH; 3,4-METHYLEN-DIOXY-BENZALDEHYDE; 3,4-Bis(methylenedioxy)benzaldehyde; AI3-01198; Dioxymethylene-protocatechuic aldehyde; 30024-74-9; HSDB 581; Piperonal; LS-631; Heliotropin | C8H6O3 | 150.13 g/mol | C1OC2=C(O1)C=C(C=C2)C=O |
| TCMBANKIN029077 | n-isobutyl-(2 e,4 e)-octadienamide | n-isobutyl-(2e,4 e)-octadienamide | C12H21NO | 195.3 g/mol | CCCC=CC=CC(=O)NCC(C)C |
| TCMBANKIN029319 | 1,8-menthadien-10-ol acetate | CC1=CCC(CC1)C(=C)COC(=O)C | |||
| TCMBANKIN029594 | 1-[1-oxo-7(3,4-methylenedioxyphenyl)-2 e,4 e,6 e-heptatrienyl]pyrrolidine | 1-[1-oxo-7(3,4-methylenedioxyphenyl)-2e,4 e,6 e-heptatrienyl]pyrrolidine | C1CCN(C1)C(=O)C=CC=CC=CC2=CC3=C(C=C2)OCO3 | ||
| TCMBANKIN029844 | 5-(4-Hydroxybut-1-ynyl)-2,2'-bithiophene | 4-[5-(2-thienyl)-2-thienyl]but-3-yn-1-ol; C04486; 3-Butyn-1-ol, 4-[2,2'-bithiophen]-5-yl-; AIDS-035248; 3-Butyn-1-ol, 4-(5-(2-thienyl)-2-thienyl)-; AIDS035248; CHEBI:16887; 1137-87-7; 5-(4-hydroxy-but-1-ynyl)-2,2'-bithiophene; 4-(2,2'-bithien-5-yl)but-3-yn-1-ol; 4-(5-(2-Thienyl)-2-thienyl)-3-butyn-1-ol; 4-(5-thiophen-2-ylthiophen-2-yl)but-3-yn-1-ol | C12H10OS2 | 234.34 | C1=CSC(=C1)C2=CC=C(S2)C#CCCO |
| TCMBANKIN029867 | 1,8,8-trimethyl-5-methylenecycloundeca-1,6-diene | (1Z,6Z)-1,8,8-trimethyl-5-methylidenecycloundeca-1,6-diene; 1,8,8-trimethyl-5-methylidenecycloundeca-1,6-diene; (1Z,6Z)-1,8,8-trimethyl-5-methylidene-cycloundeca-1,6-diene; (1Z,6Z)-1,8,8-trimethyl-5-methylenecycloundeca-1,6-diene; 1,8,8-trimethyl-5-methylidene-cycloundeca-1,6-diene; (1Z,6Z)-1,8,8-trimethyl-5-methylene-cycloundeca-1,6-diene; 1,8,8-trimethyl-5-methylene-cycloundeca-1,6-diene | C15H24 | 204.35 | CC1=CCCC(=C)C=CC(CCC1)(C)C |
| TCMBANKIN031225 | guaiene | beta-guaiene; β-guaiene | C15H24 | 204.35 | CC1CCC(=C(C)C)CC2=C1CCC2C |
| TCMBANKIN032510 | coumaperine | C16H19NO2 | 257.33 | C1CCN(CC1)C(=O)C=CC=CC2=CC=C(C=C2)O | |
| TCMBANKIN034052 | n-isobutyl-4,5-epoxy-2 e-decaenamide | n-isobutyl-4,5-epoxy-2e-decaenamide | C14H25NO2 | CCCCCC1C(O1)C=CC(=O)NCC(C)C | |
| TCMBANKIN034170 | (1S,6R)-6-isopropyl-3-methyl-1-cyclohex-3-enol | (1S,6R)-3-methyl-6-propan-2-ylcyclohex-3-en-1-ol; (1S,6R)-3-methyl-6-propan-2-yl-cyclohex-3-en-1-ol; (1S,6R)-6-isopropyl-3-methyl-cyclohex-3-en-1-ol | C10H18O | 154.25 | |
| TCMBANKIN035365 | cis-p-2,8-Menthadien-1-ol | 1-Methyl-4-(1-methylethenyl)-2-cyclohexen-1-ol cis-; (1R,4S)-1-methyl-4-prop-1-en-2-ylcyclohex-2-en-1-ol; (1R,4S)-1-methyl-4-prop-1-en-2-yl-cyclohex-2-en-1-ol; 3886-78-0; 2-Cyclohexen-1-ol, 1-methyl-4-(1-methylethenyl)-, cis-; (1R,4S)-4-isopropenyl-1-methyl-cyclohex-2-en-1-ol; (1R,4S)-4-isopropenyl-1-methyl-1-cyclohex-2-enol; cis-p-2,8-menthadien-1-ol | C10H16O | 152.23 | CC(=C)C1CCC(C=C1)(C)O |
| TCMBANKIN035371 | 1-[1-oxo-3(3,4-methylenedioxyphenyl)-2 e-propenyl]pyrrolidine | 1-[1-oxo-3(3,4-methylenedioxyphenyl)-2e-propenyl]pyrrolidine | C1CCN(C1)C(=O)C=CC2=CC3=C(C=C2)OCO3 | ||
| TCMBANKIN035647 | n-isobutyl-2 e,4 e-dodedienamide | n-isobutyl-2e,4 e-dodedienamide | C16H29NO | CCCCCCCC=CC=CC(=O)NCC(C)C | |
| TCMBANKIN036842 | piperine | KBio2_003371; AIDS024972; SPBio_002547; ZINC01529772; Piperidine, 1-[5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]-, (E,E)-; 1-[5-(3,4-Methylenedioxyphenyl)-1-oxo-2,4-pentadienyl]piperidine; DivK1c_000954; NSC242267; CCRIS 5572; 1-(5-(1,3-Benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)piperidine, (E,E)-; P49007_ALDRICH; BSPBio_000608; 7780-20-3; Piperidine, 1-[5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]-; 1-[5-(3,4-pentadienyl]piperidine; Piperin; Piperidine, 1-(5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)-, (E,E)-; Piperine (aliphatic); piperine ; SCHEMBL14171509; Spectrum2_000049; KBioSS_000803; 1-PIPEROYL-(E,E)-PIPERIDINE; ZINC5945454; IDI1_000954; (2E,4E)-5-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylpenta-2,4-dien-1-one; Piperidine, 1-(5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)-, (Z,E)-; NCGC00094872-03; Prestwick1_000474; 1-Piperoyl-piperidine; InChI=1/C17H19NO3/c19-17(18-10-4-1-5-11-18)7-3-2-6-14-8-9-15-16(12-14)21-13-20-15/h2-3,6-9,12H,1,4-5,10-11,13H2/b6-2+,7-3; NCGC00094872-01; Piperidine, 1-piperoyl-, (E,E)-; Piperidine, 1-[5-(3,4-methylenedioxyphenyl)-1-oxo-2,4-pentadienyl]-; SR-01000638580-1; Piperidine,4-methylenedioxyphenyl)-1-oxo-2,4-pentadienyl]-; UNII-Z3C7H03C5M; KBio1_000954; BPBio1_000670; N-[(E,E)-piperoyl]-piperidine; 1-Piperoylpiperidine; Piperidine, 1-(5-(3,4-methylenedioxyphenyl)-1-oxo-2,4-pentadienyl)-; 5-(1,3-benzodioxol-5-yl)-1-piperidino-penta-2,4-dien-1-one; NCGC00094872-02; Z3C7H03C5M; (2Z,4E)-5-(2H-1,3-BENZODIOXOL-5-YL)-1-(PIPERIDIN-1-YL)PENTA-2,4-DIEN-1-ONE; piperidine, 1-[(2E,4E)-5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]-; NSC21727; 1-(5-(3,4-Methylenedioxyphenyl)-1-oxo-2,4-pentadienyl)piperidine; Spectrum_000323; (2Z,4E)-5-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylpenta-2,4-dien-1-one; 1,3-Benzodioxol-5-yl-1-oxo-2,4-pentadienyl-piperine; (E,E) 1-[5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]piperidine; (2E,4E)-5-(1,3-benzodioxol-5-yl)-1-(1-piperidyl)penta-2,4-dien-1-one; Piperidine, 1-(5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)-, (E,E)- (9CI); Spectrum4_000708; 1-Piperoylpiperidine, (E,E)-; KBio3_002015; Prestwick3_000474; AIDS-024972; Spectrum3_000868; KBio2_005939; Prestwick_398; Prestwick0_000474; Prestwick2_000474; Piperidine, 1-((2E,4E)-5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)-; (E,E)-1-piperoylpiperidine; FEMA No. 2909; SPBio_000177; C03882; 147030-08-8; N-[(E,E)-Piperoyl]piperidine; 80810_FLUKA; Piperoylpiperidine; 5-(1,3-benzodioxol-5-yl)-1-(1-piperidyl)penta-2,4-dien-1-one; Spectrum5_001507; 94-62-2; 1-[(2E,4E)-5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]piperidine; W290904_ALDRICH; NINDS_000954; BSPBio_002515; 5-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylpenta-2,4-dien-1-one; 1-[(2E,4E)-5-(1,3-benzodioxol-5-yl)-2,4-pentadienoyl]piperidine; 1-[(2E,4E)-5-(1,3-benzodioxol-5-yl)penta-2,4-dienoyl]piperidine; Piperine; 5-(1,3-benzodioxol-5-yl)-1-piperidin-1-yl-penta-2,4-dien-1-one; Piperidine,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]-; KBioGR_001235; (2E,4E)-5-(1,3-benzodioxol-5-yl)-1-piperidino-penta-2,4-dien-1-one; NSC 242267; AC1LU7IP; SDCCGMLS-0066693.P001; AI3-01439; NSC 21727; Isopiperine; KBio2_000803; Piperidine, 1-(5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)-; (2E,4E)-5-(1,3-benzodioxol-5-yl)-1-piperidin-1-yl-penta-2,4-dien-1-one; CHEBI:28821; ST5307921; 30511-76-3; NSC-242267; SPECTRUM1500873; EINECS 202-348-0 | C17H19NO3 | 285.338 | c12c(OC([H])([H])O1)c([H])c([H])c(\C([H])=C([H])\C([H])=C([H])\C(=O)N3C([H])([H])C([H])([H])C([H])([H])C([H])([H])C3([H])[H])c2[H] |
| TCMBANKIN036888 | Pinocembrin | Spectrum5_000349; KBio3_002549; AIDS014893; (R)-5,7-Dihydroxy-2-phenylchroman-4-one; NCGC00017205-02; SDCCGMLS-0066749.P001; ZB000598; SpecPlus_000896; (-)-pinocembrin; pinocembrine; (2S)-5,7-dihydroxy-2-phenyl-4-chromanone; Spectrum_001879; AKOS030254805; KBio2_004969; URFCJEUYXNAHFI-CYBMUJFWSA-N; NCGC00017205-01; Spectrum3_001635; 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-phenyl-, (S)-(-)-; ST023293; 5,7-Dihydroxyflavanone; BSPBio_003329; ZINC00073693; 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-phenyl-, (2R)-; (S)-2,3-Dihydro-5,7-dihydroxy-2-phenyl-4H-1-benzopyran-4-one; AK582703; 206660-42-6; KBio2_007537; NCGC00142377-01; (2S)-5,7-dihydroxy-2-phenylchroman-4-one; TNP00071; Pinocembrin (6CI); NSC 279005; (2R)-5,7-dihydroxy-2-phenyl-2,3-dihydrochromen-4-one; SCHEMBL10080882; Oprea1_508274; (R)-PINOCEMBRIN; DivK1c_006992; (2R)-5,7-dihydroxy-2-phenyl-3,4-dihydro-2H-1-benzopyran-4-one; A836234; SPBio_001859; Spectrum2_001670; AIDS-014893; KBioSS_002406; KBio2_002401; CTK0J0172; AC1LDIB9; (2R)-5,7-bis(oxidanyl)-2-phenyl-2,3-dihydrochromen-4-one; N2094; NSC 661207; (2R)-5,7-dihydroxy-2-phenylchroman-4-one; ZINC4935; BDBM26666; 480-39-7; KBioGR_002249; DTXSID30349853; CHEMBL399249; pinocembrin; ST024705; C09827; KBio1_001936; (R)-5,7-dihydroxyflavanone; (2S)-5,7-dihydroxy-2-phenyl-chroman-4-one; (2R)-5,7-DIHYDROXY-2-PHENYL-2,3-DIHYDRO-1-BENZOPYRAN-4-ONE; NSC 43318; Spectrum4_001765 | C16H14O4 | 270.28 | c1([H])c([H])c([H])c([C@@]2([H])Oc(c([H])c(C([H])([H])O[H])c([H])c3O[H])c3C(=O)C2([H])[H])c([H])c1[H] |
| TCMBANKIN036901 | myristic acid | 1-Tridecanecarboxylic acid; Myristinsaeure; CH3-[CH2]12-COOH; 70079_FLUKA; AI3-15381; LMFA01010014; CH3-[CH2]12-COO(-); NCGC00091068-02; Myristic acid-[9,10-3H]; C06424; Emery 655; myristic acid ; NSC 5028; 70082_FLUKA; C14 fatty acid; ST023797; W276405_ALDRICH; CCRIS 4724; Kortacid 1499; 3uev; TUNFSRHWOTWDNC-UHFFFAOYSA-M; Tetradecanoic acid; EINECS 250-924-5; n-Tetradecoic acid; 4-02-00-01126 (Beilstein Handbook Reference); Hydrofol acid 1495; MYR; BRN 0508624; Myristate; Myristic acid (natural); Tetradecanoate; LS-190125; Crodacid; Myristic acid (8CI); EINECS 208-875-2; Prifac 2942; Myristic acid; AIDS002505; tetradecoate; W276413_ALDRICH; FEMA No. 2764; HSDB 5686; Philacid 1400; CHEBI:28875; Edenor C 14; n-tetradecoate; 45184-05-2; myristicacid; tetradecoic acid; n-Tetradecanoic acid; M3128_SIGMA; AIDS-002505; Univol U 316S; Lead dimyristate; AC1N2PSK; NCGC00091068-01; neo-Fat 14; NSC5028; Tetradecanoic acid (9CI); Hystrene 9014; Myristic acid, pure; M4792_SIGMA; CHEBI:30807; n-Tetradecan-1-oic acid; WLN: QV13; 1-tetradecanecarboxylate; 32112-52-0; n-tetradecan-1-oate; 544-63-8 | C14H28O2 | 228.371 | C([H])([H])(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(O[H])=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] |
| TCMBANKIN037120 | piperanine | trans-5-(3,4-methylenedioxyphenyl)-2-pentenoic acid piperidide; (E)-5-(1,3-benzodioxol-5-yl)-1-(1-piperidyl)pent-2-en-1-one; SCHEMBL15159492; ZINC1714287; 23512-46-1; Da,b-Dihydropiperine; NSC125180; NSC-125180; 2-Penten-1-one, 5-(1,3-benzodioxol-5-yl)-1-(1-piperidinyl)-, (2E)-; SMR001397304; Piperanin; AC1NSZOK; (2E)-5-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)pent-2-en-1-one; b-Hydropiperylpiperidine; MLS002473216; 1-[5-(1,3-Benzodioxol-5-yl)-1-oxo-2-pentenyl]piperidine; AC1Q5K4G; 5-(1,3-benzodioxol-5-yl)-1-(1-piperidyl)pent-2-en-1-one; (E)-5-(1,3-benzodioxol-5-yl)-1-piperidin-1-yl-pent-2-en-1-one; ACon1_000146; QHWOFMXDKFORMO-XVNBXDOJSA-N; 4,5-Dihydroxypiperine; BDBM50415870; NP-000505; NCGC00180838-01; (E)-5-(1,3-benzodioxol-5-yl)-1-piperidino-pent-2-en-1-one; 1-[5-(3,4-Methylenedioxyphenyl)-2-pentenoyl]piperidine; (E)-5-(benzo[d][1,3]dioxol-5-yl)-1-(piperidin-1-yl)pent-2-en-1-one; Piperidine, 1-[5-(1,3-benzodioxol-5-yl)-1-oxo-2-pentenyl]-, (E)-; 65937-41-9; Delata-Alpha,Beta-Dihydropiperine; BRD-K72444591-001-01-1; (E)-5-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylpent-2-en-1-one; piperanine; AKOS030555239; 5-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylpent-2-en-1-one; 5-(1,3-benzodioxol-5-yl)-1-piperidin-1-yl-pent-2-en-1-one; Piperidine, 1-(5-(1,3-benzodioxol-5-yl)-1-oxo-2-pentenyl)-, (E)-; 5-(1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)pent-2-en-1-one; CHEMBL256218; Piperanine, >=95% (LC/MS-ELSD); MolPort-001-740-383; MEGxp0_000204; Dalpha,Beta-Dihydropiperine; Piperidine, 1-[5-[3,4-(methylenedioxy)phenyl]-2-pentenoyl]-, (E)-; MCULE-5426651801; AK585636; NCGC00180838-02!(E)-5-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylpent-2-en-1-one; 5-(Benzo[d][1,3]dioxol-5-yl)-1-(piperidin-1-yl)pent-2-en-1-one; Piperidine, 1-[(2E)-5-(1,3-benzodioxol-5-yl)-1-oxo-2-pentenyl]-; 5-(1,3-benzodioxol-5-yl)-1-piperidino-pent-2-en-1-one; 5-(3,4-Methylenedioxyphenyl)-2-pentenoic acid piperidide; HMS2270O08 | C17H21NO3 | 287.354 | C1([H])([H])Oc(c([H])c([H])c(C([H])([H])C([H])([H])\C([H])=C([H])\C(=O)N2C([H])([H])C([H])([H])C([H])([H])C([H])([H])C2([H])[H])c3[H])c3O1 |
| TCMBANKIN037541 | alpha-Cubebene | α-cubebene; α- cubebene; 17699-14-8; alpha-cubebene; C09647 | C15H24 | 204.351 | C([H])([H])([H])[C@@]1([H])[C@@]2([C@]3([H])C(C([H])([H])[H])=C([H])C2([H])[H])[C@@]3([H])[C@]([H])(C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C1([H])[H] |
| TCMBANKIN038043 | 1-Terpinen-5-ol | ||||
| TCMBANKIN038259 | Octanoic acid | octanoic acid ; O-octanoyl-L-carnitine; (3-carboxylato-2-octanoyloxy-propyl)-trimethyl-ammonium; octanoylcarnitine; (-)-Octanoylcarnitine; L-Carnitine octanoyl ester; UNII-S1HB7P0O16 component CXTATJFJDMJMIY-CYBMUJFWSA-N; L-Octanoylcarnitine; L-O-Octanoylcarnitine; O-octanoyl-(R)-carnitine; (3R)-3-octanoyloxy-4-(trimethylammonio)butanoate; Octanoic acid ester with L-(3-carboxy-2-hydroxypropyl)trimethylammonium hydroxide inner salt; C02838; O-octanoyl-R-carnitine; Octanoyl-L-carnitine, >=97.0% (TLC); CHEBI:18102; LMFA07070002; SCHEMBL2915508 | C8H16O2 | 144.211 | C([H])([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(=O)O[H] |
| TCMBANKIN038565 | pipercycliamide | CCCCCC(=O)C1(CCC(=O)N1CC(C)C)O | |||
| TCMBANKIN039806 | Sarmentosine | 4CN-1777; (Z)-2-methylol-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-but-2-enenitrile; (Z)-2-(hydroxymethyl)-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-but-2-enenitrile; (Z)-2-(hydroxymethyl)-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-but-2-enenitrile; 2-Butenenitrile, 4-(beta-D-glucopyranosyloxy)-2-(hydroxymethyl)-, (E)-; (Z)-2-(hydroxymethyl)-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybut-2-enenitrile; AC1O5Q6P; (Z)-2-(hydroxymethyl)-4-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]but-2-enenitrile; AKOS032948571; Sarmentosine | 275.25 g/mol | ||
| TCMBANKIN041429 | 1-[1-Oxo-3(3,4-methylenedioxyphenyl)propyl]piperidine | ||||
| TCMBANKIN041934 | Pipercide | 355.47 | |||
| TCMBANKIN043752 | sesquisabinene | CTK8J4569; 58319-04-3; 1-(6-methylhept-5-en-2-yl)-4-methylidenebicyclo[3.1.0]hexane; Sesquisabinene isomer; 1-(1,5-Dimethyl-4-hexenyl)-4-methylenebicyclo[3.1.0]hexane, 9CI; (1R,5R)-4-Methylene-1-((R)-6-methylhept-5-en-2-yl)bicyclo[3.1.0]hexane, (relative configuration); DYUSFBWNOCHOFP-UHFFFAOYSA-N | C15H24 | 204.35 | CC(CCC=C(C)C)C12CCC(=C)C1C2 |
| TCMBANKIN044719 | Piperamine | ZINC987; 4945-47-5; Bamipinum [INN-Latin]; 61732-85-2 (di-hydrochloride); 1229-69-2 (mono-hydrochloride); bamipine citrate; AC1Q4TRO; API0000415; Bamipine; 4-Piperidinamine, 1-methyl-N-phenyl-N-(phenylmethyl)-; AKOS015960825; Y6BHZ28O92; D07197; Bamipinum; bamipine monohydrochloride; CHEBI:135165; DSSTox_RID_97425; 4-(N-Benzyl-N-phenylamino)-1-methylpiperidine; AK327087; N-benzyl-1-methyl-N-phenylpiperidin-4-amine; DTXSID5057751; Piperamine; LS-114300; Soventol; N-Phenyl-N-benzyl-4-amino-1-methyl-piperidine; Piperidine, 4-(N-benzyl-N-phenylamino)-1-methyl-; 1-Methyl-N-phenyl-N-(phenylmethyl)-4-piperidinamine; Bamipina; 4-(N-Benzylanilino)-1-methylpiperidine; MFCD00797515; N-Benzyl-1-methyl-N-phenyl-4-piperidinamine #; AC1L2HD7; Bamipina [INN-Spanish]; BRN 0252193; taumidrine; CAS-4945-47-5; bamipin; VZSXTYKGYWISGQ-UHFFFAOYSA-N; EINECS 225-587-2; N-Phenyl-N-benzyl-4-amino-1-methyl-piperidin [German]; 61670-09-5 (lactate); NCGC00253769-01; Bamipine (INN); Bamipine [INN:BAN:DCF]; SCHEMBL29626; CHEMBL520400; UNII-Y6BHZ28O92; N-Phenyl-N-benzyl-4-amino-1-methyl-piperidin; ACM4945475; Tamidrine; DSSTox_GSID_57751; Tox21_113882; DSSTox_CID_31540; 5-22-08-00036 (Beilstein Handbook Reference); bamipine dihydrochloride hydrate; Bamipine dihydrochloride | 280.4 g/mol | ||
| TCMBANKIN044989 | pipyahyine | CC(C)CCNC(=O)C=CC=CCCCCCC=CC1=CC2=C(C=C1)OCO2 | |||
| TCMBANKIN046171 | retrofractamide A | BPSWISYORIWKCT-FCGWLDPVSA-N; CHEMBL255152; RETROFRACTAMIDE A; 94079-67-1; Retrofractamide-A; NP-000509; Retrofractamid-A; (2E,4E,8E)-9-(2H-1,3-benzodioxol-5-yl)-N-(2-methylpropyl)nona-2,4,8-trienamide; SCHEMBL14025730 | C20H25NO3 | 327.417 | c1([H])c(\C([H])=C([H])\C([H])([H])C([H])([H])\C([H])=C([H])\C([H])=C([H])\C(=O)N([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])c([H])c([H])c(OC([H])([H])O2)c12 |
| TCMBANKIN046676 | Pellitorin | AIDS210374; 2,4-Decadienamide, N-(2-methylpropyl)-; (2E,4E)-N-isobutyldeca-2,4-dienamide; 4-04-00-00636 (Beilstein Handbook Reference); N-Isobutyldeca-trans-2-trans-4-dienamide; (E,E)-N-Isobutyl-2,4-decadienamide; 2,4-Decadienamide, N-(2-methylpropyl)-, (E,E)-; AI3-19560; Pellitorine; trans-Pellitorin; (2E,4E)-N-(2-methylpropyl)deca-2,4-dienamide; (E,E)-N-(2-Methylpropyl)-2,4-decadienamide; 2,4-DECADIENAMIDE, N-ISOBUTYL-, (E,E)-; MEGxp0_000048; N-(2-Methylpropyl)-2,4-Decadienamide; 2,4-Decadienamide, N-(2-methylpropyl)-, (2E,4E)-; 53608-76-7; BRN 1725967; Pellitorine (6CI); 109-26-2; N-Isobutyldeca-trans-2,trans-4-dienamide; AIDS-210374; 18836-52-7 | C14H25NO | 223.35 | CCCCCC=CC=CC(=O)NCC(C)C |
| TCMBANKIN048657 | Neopellitorine B | 235.36 g/mol | |||
| TCMBANKIN049172 | 1-(1-oxo-3-phenyl-2e-propenyl)piperidine | C1CCN(CC1)C(=O)C=CC2=CC=CC=C2 | |||
| TCMBANKIN049487 | Pipnoohine | 361.6 g/mol | |||
| TCMBANKIN057941 | l-ascorbic acid;ascorbicacid | l-ascorbic acid;ascorbic acid ; LS-187838 | C6H8O6 | 176.12 g/mol | C(C(C1C(=C(C(=O)O1)O)O)O)O |
| TCMBANKIN058015 | 1(7),8(10)-p-menthadien-9-ol | 1-(4-methylidenecyclohexyl)ethenol; AC1NSXYP;1-(4-methylidenecyclohexyl)ethenol; 1(7),8(10)-p-Menthadien-9-ol;2-(4-Methylenecyclohexyl)-2-propen-1-ol; 2-(4-methylidenecyclohexyl)prop-2-en-1-ol; 2-(4-methylenecyclohexyl)prop-2-en-1-ol; 29548-13-8; p-Mentha-1(7),8(10)-dien-9-ol;p-Mentha-1(7),8(10)-dien-9-ol;BETA,4-BIS(METHYLENE)CYCLOHEXANEETHANOL;p-mentha-1(7),8(10)-dien-9-ol;1-(4-methylenecyclohexyl)ethenol | C10H16O | 152.23 g/mol | C=C1CCC(CC1)C(=C)CO |
| TCMBANKIN058041 | chavicol | Phenol,4-(2-propen-1-yl)-; Phenol, p-allyl- (8CI); I14-56356; .gamma.-(p-Hydroxyphenyl)-.alpha.-propylene; alpha -propylene; AC1Q7A4U; 3-(p-Hydroxyphenyl)-1-propene; LS-167638; 4-Allylphenol; p-Chavicol; EINECS 207-929-2; NSC-290195; laquo gammaRaquo -(p-hydroxyphenyl)-alpha -propylene; MFCD01940501; SCHEMBL30870; W-4067; AKOS006278514; p-Allylphenol; KS-000009EP; NSC290195; AB0197728; 501A928; CCRIS 3208; MCULE-8960123940; 4-(2-propenyl)-phenol; RGIBXDHONMXTLI-UHFFFAOYSA-; 4-(Prop-2-enyl)-phenol; CHEBI:50158; CHEMBL108862; InChI=1/C9H10O/c1-2-3-8-4-6-9(10)7-5-8/h2,4-7,10H,1,3H2; CHAVICOL; Phenol, 4-(2-propenyl)-; p-Allyl-Phenol; AN-21426; p-Hydroxyallylpropene; NSC 290195; ZINC1565456; RGIBXDHONMXTLI-UHFFFAOYSA-N; Phenol, 4-(2-propenyl)- (9CI); UNII-T5721BH5Z4 component RGIBXDHONMXTLI-UHFFFAOYSA-N; KB-239888; AC1L294Y; Phenol, p-allyl-; 4-prop-2-enylphenol; 501-92-8; SC-22043; 4-(prop-2-en-1-yl)phenol; 3-(4-Hydroxyphenyl)-1-propene; UNII-Q5ER4K6969; 4-(2-Propenyl)phenol; p-Hydroxyallylbenzene; CJ-24615; BBL018739; C16930; 4-Allyl-Phenol; Q5ER4K6969; CTK4J2234; DTXSID60198210; MolPort-006-111-494; gamma-(p-Hydroxyphenyl)-alpha-propylene; Chavicol;4-allylphenol;4-(2-propenyl)- phenol | C9H10O | 134.18 | C=CCC1=CC=C(C=C1)O |
| TCMBANKIN058314 | benzaldehyde | SCHEMBL896024; A804633;Benzoic aldehyde;WLN: VHR;InChI=1/C7H6O/c8-6-7-4-2-1-3-5-7/h1-6; CHEBI:17169; Benzene methylal; B1334_ALDRICH; Ald3-H_000012; Benzenecarbonal; Benzaldehyde (natural); NCGC00091819-01; AI3-09931; EINECS 202-860-4; Oil of Bitter Almond; ST5213372; Artificial essential oil of almond; nchembio814-comp15; LS-27; EPA Pesticide Chemical Code 008601; BENZALDEHYDE; W212709_ALDRICH; Ald3.1-H_000160; D02314; Benzenemethylal; NCI-C56133; HSDB 388; 12010_FLUKA; Ald3.1-H_000479; Benzaldehyde FFC; W212717_ALDRICH; Benzene carbaldehyde; CCRIS 2376; 100-52-7; Benzaldehyde [UN1990] [Class 9]; Caswell No. 076; Benzenecarboxaldehyde; Benzoyl hydride; Ald3.1-H_000798; Benzaldehyde (NF); Artificial Almond Oil; Benzaldehyde [USAN]; Artificial Bitter Almond Oil; 09143_FLUKA; C00261; Synthetic oil of bitter almond; FEMA No. 2127; ghl.PD_Mitscher_leg0.170; c0279; 418099_ALDRICH; Benzoic aldehyde; Benzene carboxaldehyde; benzanoaldehyde; Bitter almond oil, synthetic; UN1990; NSC7917; Almond Artificial Essential Oil; NSC 7917; Benzadehyde; Phenylmethanal | C7H6O | 106.12 | C1=CC=C(C=C1)C=O |
| TCMBANKIN058618 | Trichostachine | ACon1_000155; 5-(1,3-benzodioxol-5-yl)-1-pyrrolidin-1-ylpenta-2,4-dien-1-one; 25924-78-1; Pyrrolidine, 1-[5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]-, (E,E)-; trichostachine; MEGxp0_000203; 54976-54-4; 5-(1,3-benzodioxol-5-yl)-1-pyrrolidin-1-yl-penta-2,4-dien-1-one; Pyrrolidine, 1-piperoyl-, (E,E)-; 5-(1,3-benzodioxol-5-yl)-1-1-pyrrolidinylpenta-2,4-dien-1-one; Pyrrolidine, 1-(5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)-; C10174; 1-(5-(1,3-Benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)pyrrolidine; (2E,4E)-5-(1,3-benzodioxol-5-yl)-1-1-pyrrolidinylpenta-2,4-dien-1-one; (2E,4E)-5-(1,3-benzodioxol-5-yl)-1-pyrrolidin-1-yl-penta-2,4-dien-1-one; (2E,4E)-5-(1,3-benzodioxol-5-yl)-1-pyrrolidin-1-ylpenta-2,4-dien-1-one; 1-[1-oxo-5(3,4-methylenedioxyphenyl)-2z,4 e-pentadienyl] pyrrolidine | C16H17NO3 | 271.31 | C1CCN(C1)C(=O)C=CC=CC2=CC3=C(C=C2)OCO3 |
| TCMBANKIN058619 | isochavicine | KBio2_003371; AIDS024972; SPBio_002547; ZINC01529772; Piperidine, 1-[5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]-, (E,E)-; 1-[5-(3,4-Methylenedioxyphenyl)-1-oxo-2,4-pentadienyl]piperidine; DivK1c_000954; NSC242267; CCRIS 5572; Chavicine; UNII-95JV386FPD; AC1LU7IN; CAS-94-62-2; SCHEMBL119081; CHEMBL1395862; piperine; chavicine; isopiperine; (Z,Z)-1-(5-(1,3-Benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)piperidine; NCGC00016355-01; Chavicin; 95JV386FPD; 495-91-0; cis-Piperine; Piperidine, 1-[5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]-, (Z,Z)-; MXXWOMGUGJBKIW-PORYWJCVSA-N; (2Z,4Z)-5-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylpenta-2,4-dien-1-one; ZINC5368587; Piperidine, 1-(5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)-, (Z,Z)-; 1-(5-(1,3-Benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)piperidine, (E,E)-; P49007_ALDRICH; BSPBio_000608; 7780-20-3; Piperidine, 1-[5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]-; 1-[5-(3,4-pentadienyl]piperidine; Piperin; Piperidine, 1-(5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)-, (E,E)-; Piperine (aliphatic); piperine ; SCHEMBL14171509; Spectrum2_000049; KBioSS_000803; 1-PIPEROYL-(E,E)-PIPERIDINE; ZINC5945454; IDI1_000954; (2E,4E)-5-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylpenta-2,4-dien-1-one; Piperidine, 1-(5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)-, (Z,E)-; NCGC00094872-03; Prestwick1_000474; 1-Piperoyl-piperidine; InChI=1/C17H19NO3/c19-17(18-10-4-1-5-11-18)7-3-2-6-14-8-9-15-16(12-14)21-13-20-15/h2-3,6-9,12H,1,4-5,10-11,13H2/b6-2+,7-3; NCGC00094872-01; Piperidine, 1-piperoyl-, (E,E)-; Piperidine, 1-[5-(3,4-methylenedioxyphenyl)-1-oxo-2,4-pentadienyl]-; SR-01000638580-1; Piperidine,4-methylenedioxyphenyl)-1-oxo-2,4-pentadienyl]-; UNII-Z3C7H03C5M; KBio1_000954; BPBio1_000670; N-[(E,E)-piperoyl]-piperidine; 1-Piperoylpiperidine; Piperidine, 1-(5-(3,4-methylenedioxyphenyl)-1-oxo-2,4-pentadienyl)-; 5-(1,3-benzodioxol-5-yl)-1-piperidino-penta-2,4-dien-1-one; NCGC00094872-02; Z3C7H03C5M; (2Z,4E)-5-(2H-1,3-BENZODIOXOL-5-YL)-1-(PIPERIDIN-1-YL)PENTA-2,4-DIEN-1-ONE; piperidine, 1-[(2E,4E)-5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]-; NSC21727; 1-(5-(3,4-Methylenedioxyphenyl)-1-oxo-2,4-pentadienyl)piperidine; Spectrum_000323; (2Z,4E)-5-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylpenta-2,4-dien-1-one; 1,3-Benzodioxol-5-yl-1-oxo-2,4-pentadienyl-piperine; (E,E) 1-[5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]piperidine; (2E,4E)-5-(1,3-benzodioxol-5-yl)-1-(1-piperidyl)penta-2,4-dien-1-one; Piperidine, 1-(5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)-, (E,E)- (9CI); Spectrum4_000708; 1-Piperoylpiperidine, (E,E)-; KBio3_002015; Prestwick3_000474; AIDS-024972; Spectrum3_000868; KBio2_005939; Prestwick_398; Prestwick0_000474; Prestwick2_000474; Piperidine, 1-((2E,4E)-5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)-; (E,E)-1-piperoylpiperidine; FEMA No. 2909; SPBio_000177; C03882; 147030-08-8; N-[(E,E)-Piperoyl]piperidine; 80810_FLUKA; Piperoylpiperidine; 5-(1,3-benzodioxol-5-yl)-1-(1-piperidyl)penta-2,4-dien-1-one; Spectrum5_001507; 94-62-2; 1-[(2E,4E)-5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]piperidine; W290904_ALDRICH; NINDS_000954; BSPBio_002515; 5-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylpenta-2,4-dien-1-one; 1-[(2E,4E)-5-(1,3-benzodioxol-5-yl)-2,4-pentadienoyl]piperidine; 1-[(2E,4E)-5-(1,3-benzodioxol-5-yl)penta-2,4-dienoyl]piperidine; Piperine; 5-(1,3-benzodioxol-5-yl)-1-piperidin-1-yl-penta-2,4-dien-1-one; Piperidine,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]-; KBioGR_001235; (2E,4E)-5-(1,3-benzodioxol-5-yl)-1-piperidino-penta-2,4-dien-1-one; NSC 242267; AC1LU7IP; SDCCGMLS-0066693.P001; AI3-01439; NSC 21727; Isopiperine; KBio2_000803; Piperidine, 1-(5-(1,3-benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)-; (2E,4E)-5-(1,3-benzodioxol-5-yl)-1-piperidin-1-yl-penta-2,4-dien-1-one; CHEBI:28821; ST5307921; 30511-76-3; NSC-242267; SPECTRUM1500873; EINECS 202-348-0 | C17H19NO3 | 285.34 g/mol | C1CCN(CC1)C(=O)C=CC=CC2=CC3=C(C=C2)OCO3 |
| TCMBANKIN058620 | 1-[1-oxo-3(3,4-methylenedioxyphenyl)-2z-propenyl]piperidine | C1CCN(CC1)C(=O)C=CC2=CC3=C(C=C2)OCO3 | |||
| TCMBANKIN058621 | 1-[1-oxo-9(3,4-methylenedioxyphenyl)-2 e,8 e-nonadienyl] piperidine | 1-[1-oxo-9(3,4-methylenedioxyphenyl)-2e,8 e-nonadienyl] piperidine | C1CCN(CC1)C(=O)C=CCCCCC=CC2=CC3=C(C=C2)OCO3 | ||
| TCMBANKIN058622 | piperoleine a | Piperidine, 1-[7-[3,4-(methylenedioxy)phenyl]-6-heptenoyl]-, (E)-; Piperidine, 1-[7-(1,3-benzodioxol-5-yl)-1-oxo-6-heptenyl]-, (E)-; (6E)-7-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)hept-6-en-1-one; Piperolein A; CHEMBL1086887; (E)-Piperolein A; ZINC13838497; Piperolein A, >=90% (LC/MS-UV); 6-Hepten-1-one, 7-(1,3-benzodioxol-5-yl)-1-(1-piperidinyl)-, (6E)-; Piperoleine A; Piperidine, 1-[(6E)-7-(1,3-benzodioxol-5-yl)-1-oxo-6-heptenyl]-; MCULE-4732915157; 7-(3',4'-Methylenedioxyphenyl)-6E-heptenoic acid piperidylamide; MolPort-019-937-397; (E)-7-(Benzo[d][1,3]dioxol-5-yl)-1-(piperidin-1-yl)hept-6-en-1-one; NP-016314; MIWPBXQTBYPJEF-XBXARRHUSA-N | C19H25NO3 | 315.4 g/mol | C1CCN(CC1)C(=O)CCCCC=CC2=CC3=C(C=C2)OCO3 |
| TCMBANKIN058623 | piperoleine b | piperolein b | C21H29NO3 | 343.5 g/mol | C1CCN(CC1)C(=O)CCCCCCC=CC2=CC3=C(C=C2)OCO3 |
| TCMBANKIN058628 | PIP | 643602_ALDRICH; LS-3053; CHEBI:18049; EINECS 203-813-0; NCIOpen2_007828; CCRIS 967; W290807_ALDRICH; Hexazane; Piperidine [UN2401] [Corrosive]; InChI=1/C5H11N/c1-2-4-6-5-3-1/h6H,1-5H; Piperidin [German]; Hexahydropyridine; FEMA No. 2908; 411027_ALDRICH; Perhydropyridine; AI3-24114; 80640_FLUKA; Pentamethylenimine; Pyridine, hexahydro-; Cyclopentimine; Piperidine solution; Piperidine; UN2401; 571261_SIAL; 80645_FLUKA; C01746; Pentamethyleneimine; Cypentil; Azacyclohexane; ST5213814; 33537_RIEDEL; HSDB 114; Piperidine on Rasta Resin; 104094_SIAL; 110-89-4; NCIMech_000312;BG00956967; BCP0726000204; AN-3762; DTXSID30705359; (7bR,10aR)-2,3,4,7B,8,9,10,10a-Octahydro-1H-cyclopenta[b][1,4]diazepino[6,7,1-hi]indolehydrochloride; CO-124; AX8163273; (11R,15R)-7,10-DIAZATETRACYCLO[8.5.1.0?,(1)?.0(1)(1),(1)?]HEXADECA-1(16),2,4-TRIENE HYDROCHLORIDE; WAY163909-HCl; (7BR,10AR)-2,3,4,7B,8,9,10,10A-OCTAHYDRO-1H-CYCLOPENTA[B][1,4]DIAZEPINO[6,7,1-HI]INDOLE HYDROCHLORIDE; AKOS016002206; 428868-35-3; PS-J-141; AK-38565; (7bR,10aR)-1,2,3,4,8,9,10,10a-Octahydro-7bH-cyclopenta[b][1,4]diazepino[6,7,1-hi]indole--hydrogen chloride (1/1); (11R,15R)-7,10-DIAZATETRACYCLO[8.5.1.0?,(1)?.0(1)(1),(1)?]HEXADECA-1,3,5(16)-TRIENE HYDROCHLORIDE; KB-277464; (7bR,10aR)-1,2,3,4,8,9,10,10a-Octahydro-7bH-cyclopenta[b][1,4]diazepino[6,7,1-hi]indole hydrochloride; (7BR,10AR)-2,3,4,7B,8,9,10,10A-Octahydro-1H-cyclopenta[b][1,4diazepino][6,7,1-HI]indole hydrochloride;piperidine | C5H11N | 85.15 g/mol | C1CCNCC1 |
| TCMBANKIN058851 | linalool | Spectrum5_000393; KBioGR_002294; KBio2_003260; KBio2_000692; (3R)-3,7-dimethylocta-1,6-dien-3-ol; W263516_ALDRICH; ZINC01529820;beta-linalool;NSC-3789; AK-50127; (+/-)-3,7-Dimethyl-1,6-octadien-3-ol; ACMC-209pf1; D0X5DC; Linalool Solution, 1000 mg/L, 1 ml (RM, ISO GUIDE 34); Linalool, primary pharmaceutical reference standard; CDOSHBSSFJOMGT-UHFFFAOYSA-N; AC1L1MRY; Howood Oil; 1,6-Octadien-3-ol, 3,7-dimethyl-, (3S)-; KSC377K8J; AC1Q1NVD; KB-179981; (+/-) LINALOOL; NCGC00259207-01; 3,6-dien-3-ol; AI3-00942; HSDB 645; (S)-Linalol; 2,7-Octadien-6-ol, 2,6-dimethyl-; 2,6-Dimethylocta-2,7-dien-6-ol; Linalool ex orange oil; (?)-3,7-Dimethyl-1,6-octadien-3-ol; DB-062552; I14-13929; FT-0614785; FCH1115719; Tox21_201658; 11024-20-7; BB_NC-00123; MolPort-001-783-101; LS-97796; 2,6-Dimethyl-2,7-octadien-6-ol; Linalool (natural); L0048; Linalool; BRN 1721488; 2,7-octadiene-6-ol; DSSTox_RID_77812; 3,7-Dimethyl-1,6-octadien-3-ol; BC207603; STL373777; AC1Q2BP3; FEMA No. 2635; ANW-37211; MCULE-2407576698; 3,6-octadien-3-ol; Natural Linalool; Linalool b; SCHEMBL20316; BBL027734; EINECS 204-811-2; LINALOOL (+); CU-01000013132-2; LINOLOOL (D); ST069326; dl-3,7-Dimethyl-3-hydroxy-1,6-octadiene; NSC 3789; CHEBI:17580; Linalool ex ho oil; Linalool, 97%; (.+/-.)-Linalool; allo-Ocimenol; GTPL2469; CCRIS 6557; ( -)-Linalool; BG00600803; NCGC00257060-01; C03985; EINECS 201-134-4; HMS2268E18; Tox21_303037; Phantol; (+-)-Linalool; SBB012353; SMR000112394; DTXSID7025502; (R)-3,7-Dimethyl-1,6-octadien-3-ol; DL -3,7-Dimethyl-3-hydroxy-1,6-octadiene; BB_NC-0123; NCGC00091688-04; (+/-)-3,7-Dimethyl-3-hydroxy-1,6-octadiene; CHEMBL25306; MLS002152908; WLN: 1Y1&U3XQ1&1U1 -,-; LINALYL ALCOHOL; Q-201306; 0-01-00-00462 (Beilstein Handbook Reference); SC-74998; CAS-78-70-6; (+/-)-linalool; LINALOOL EX BOIS DE ROSE; RTR-030706; NCGC00091688-02; Linalool, analytical standard; MFCD00008906; 1,6-OCTADIEN-3-OL, 3,7-DIMETHYL-, (-)-; Linalool, >=97%, FCC, FG; AC-551; Linolool; NSC3789; Linalool, certified reference material, TraceCERT(R); FEMA Number 2635; AKOS015901617; 3,7-Dimethyl-1, 6-octadien-3-ol; p-Linalool; Linalool ex bois de rose oil; FEMA 2635; DSSTox_CID_5502; .beta.-Linalool; EC 201-134-4; TR-030706; CTK2H7584; LS-1752; KS-00000WLW; 3,7-Dimethylocta-1,6-dien-3-ol; DSSTox_GSID_25502; WLN: 1U1XQ1&3UY1&1; 1,6-Octadien-3-ol, 3,7-dimethyl-; ( )-linalool; CCRIS 3726; Linanool; 78-70-6; NCGC00091688-03; Caswell No. 526A; AN-22986; 2,6-Dimethyl-2,7-octadiene-6-ol; (RS)-Linalool; RP21877; (1)-3,7-Dimethyl-1,6-octadien-3-ol; AN-15757; AC1Q1NVE; LINALOOL, (+-)-; NCGC00091688-01; Linalol; beta-Linalool; EINECS 245-083-6; 22564-99-4; Linalool, .beta.; 2,7-dien-6-ol; EPA Pesticide Chemical Code 128838; 1, 3,7-dimethyl-, (-)-; 3,7-dimethyl-octa-1,6-dien-3-ol;L-linalool;CJ-23937; Spectrum5_000393; LMPR0102010013; AKOS028109218; linalool ; Linalool; 1,6-Octadien-3-ol,3,7-dimethyl-, (3R)-; (R)-3,7-Dimethyl-1,6-octadien-3-ol; AC1L9E4Q; KBioGR_002294; (R)-3,7-dimethylocta-1,6-dien-3-ol; KBio2_003260; Epoxydihydrolinalool; KBio2_000692; (3R)-3,7-dimethylocta-1,6-dien-3-ol; ZINC1529820; Spectrum4_001777; C11388; linalool oxide; 126-91-0; 3U21E3V8I2; KBio3_002285; CCG-38497; CTK8F1408; KBio2_005828; KBioSS_000692; (-)-Linalool; EINECS 204-811-2; (-)-3,7-dimethyl-1,6-octadien-3-ol; LINALOOL (+); (3R)-Linalool; L-LINALOOL, REF. IND.-14<F128><144><F255>; CHEMBL235672; CHEBI:28; SpecPlus_000909; SCHEMBL891312; (-)-Linalool, analytical standard; UNII-3U21E3V8I2; KBio1_001949; J-005448; MolPort-003-666-060; NCGC00095658-01; FT-0772303; BSPBio_002785; SDCCGMLS-0066889.P001; UNII-D81QY6I88E component CDOSHBSSFJOMGT-JTQLQIEISA-N; L-Linalool; 1,6-OCTADIEN-3-OL, 3,7-DIMETHYL-, (-)-; L-Linalool, natural, >=95%, FG; SPBio_002007; Spectrum3_001173; 1,6-Octadien-3-ol, 3,7-dimethyl-, (3R)-; NCGC00095658-02; SPECTRUM1501212; SMP2_000331; (-)-Linalool, >=95.0% (sum of enantiomers, GC); Linalool, (-)-; 3R,7-dimethylocta-1,6-dien-3-ol; DivK1c_007005; (R)-linalool; (R)-(-)-3,7-Dimethyl-1,6-octadien-3-ol; DTXSID40872607; laevo-linalool; MFCD00135469; Spectrum2_001944; I14-45868; (3R)-3,7-dimethyl-1,6-octadien-3-ol; Spectrum_000212; (R)-(-)-Linalool | C10H18O | 154.25 g/mol | CC(=CCCC(C)(C=C)O)C |
| TCMBANKIN059195 | (1S,5S)-1-isopropyl-4-methylenebicyclo[3.1.0]hexane | (1S,5S)-1-isopropyl-4-methylene-bicyclo[3.1.0]hexane; (1S,5S)-4-methylidene-1-propan-2-ylbicyclo[3.1.0]hexane; (1S,5S)-4-methylidene-1-propan-2-yl-bicyclo[3.1.0]hexane | C10H16 | 136.23 g/mol | CC(C)C12CCC(=C)C1C2 |
| TCMBANKIN059206 | cryptone | InChI=1/C9H14O/c1-7(2)8-3-5-9(10)6-4-8/h3,5,7-8H,4,6H2,1-2H; (4R)-4-isopropyl-1-cyclohex-2-enone; (4R)-4-propan-2-ylcyclohex-2-en-1-one; (4R)-4-isopropylcyclohex-2-en-1-one;Cryptone, L-; Cryptone (compound); 2158-61-4; 106440-18-0; Crypton; SCHEMBL440040; Cryptone; 2-Cyclohexen-1-one, 4-(1-methylethyl)-; EINECS 207-898-5; 4-Isopropyl-2-cyclohexenone; AANMVENRNJYEMK-UHFFFAOYSA-N; 500-02-7; Cyclohexenone, 4-(1-methylethyl)-; 4-iso-Propyl-2-cyclohexenone; CRYPTONE,L-; 4-(propan-2-yl)cyclohex-2-en-1-one; 4-Isopropyl-2-cyclohexen-1-one; (R)-Cryptone; AKOS028113278; NSC22060; 2-Cyclohexen-1-one, 4-isopropyl-; AC1Q6CQF; CTK0D7235; ACMC-20c6ik; AN-21423; 4-(1-Methylethyl)-2-cyclohexen-1-one; NSC-22060; ?cryptone ; AC1L3OTJ; 21293-23-2; NSC 22060; Kryptone; 4-Isopropylcyclohex-2-enone; 4-propan-2-ylcyclohex-2-en-1-one; 4-Isopropylcyclohex-2-en-1-one;4-isopropylcyclohex-2-en-1-one | C9H14O | 138.21 g/mol | CC(C)C1CCC(=O)C=C1 |
| TCMBANKIN059208 | trans-p-2-Menthen-1-ol | (1S,4R)-4-isopropyl-1-methyl-cyclohex-2-en-1-ol; trans-p-2-menthen-1-ol; (1S,4R)-4-isopropyl-1-methyl-1-cyclohex-2-enol; (1S,4R)-1-methyl-4-propan-2-ylcyclohex-2-en-1-ol; (1S,4R)-1-methyl-4-propan-2-yl-cyclohex-2-en-1-ol;2-Cyclohexen-1-ol, 1-methyl-4-(1-methylethyl)-, trans-; 2-Cyclohexen-1-ol, 1-methyl-4-(1-methylethyl)-, (1R,4S)-rel-; (1R,4S)-4-isopropyl-1-methyl-cyclohex-2-en-1-ol; EINECS 249-859-5; trans-1-Methyl-4-(1-methylethyl)-2-cyclohexen-1-ol; 29803-81-4; (1R,4S)-1-methyl-4-propan-2-ylcyclohex-2-en-1-ol; (1R,4S)-1-methyl-4-propan-2-yl-cyclohex-2-en-1-ol; (1R,4S)-4-isopropyl-1-methyl-1-cyclohex-2-enol; 117064-02-5;trans-4-(Isopropyl)-1-methylcyclohex-2-en-1-ol | C10H18O | 154.25 | CC(C)C1CCC(C=C1)(C)O |
| TCMBANKIN059518 | 1,3,3-trimethyltricyclo[2.2.1.02,6]heptane | C10H16 | 136.23 g/mol | CC1(C2CC3C1C3(C2)C)C | |
| TCMBANKIN059521 | B- pinene;pinene;T-pinene;(-)-nopinene;beta-pinene;bicyclo[3.1.1]heptane,6,6-dimethyl-2-methylene-,(1s);1-β-pinene;()-beta-Pinene;(-)- β- pinene;laevo- β- Pinene | C10H16 | 136.23 g/mol | CC1(C2CCC(=C)C1C2)C | |
| TCMBANKIN059531 | eucalyptol | C10H18O | 154.25 g/mol | CC1(C2CCC(O1)(CC2)C)C | |
| TCMBANKIN059532 | (1R)-1, 7, 7-trimethyl-bicyclo[2.2.1]heptan-2-one | C10H16O | 152.23 g/mol | CC1(C2CCC1(C(=O)C2)C)C | |
| TCMBANKIN059571 | ZINC05224268 | C15H24 | 204.35 | CC1(CC2C1CCC3(C(O3)CCC2=C)C)C | |
| TCMBANKIN059643 | sandaracopimaric acid | C20H30O2 | 302.5 g/mol | CC1(CCC2C(=C1)CCC3C2(CCCC3(C)C(=O)O)C)C=C | |
| TCMBANKIN059827 | phenol,2,6-bis(1,1-dimethylethyl)-4-methyl | C15H24O | 220.35 g/mol | CC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C | |
| TCMBANKIN059836 | thymol | C10H14O | 150.22 | CC1=CC(=C(C=C1)C(C)C)O | |
| TCMBANKIN059868 | 2-Cyclohexen-1-one,3-methyl-6-(1-methylethyl)-;piperitone | C10H16O | 152.23 g/mol | CC1=CC(=O)C(CC1)C(C)C | |
| TCMBANKIN059901 | p-xylene | C8H10 | 106.17 | CC1=CC=C(C=C1)C | |
| TCMBANKIN059902 | 1-Methyl-4-isopropenyl-benzene | C10H12 | 132.2 g/mol | CC1=CC=C(C=C1)C(=C)C | |
| TCMBANKIN059904 | p-cymen-alpha-ol | C10H14O | 150.22 g/mol | CC1=CC=C(C=C1)C(C)(C)O | |
| TCMBANKIN059905 | p-isopropyltoluene;4-Isopropyltoluene;cymene;1-methyl-4-(1-methylethyl)benzene;Cymol;Para cymene;4-Cymol;p-cymene;Dolcymene | C10H14 | 134.22 g/mol | CC1=CC=C(C=C1)C(C)C | |
| TCMBANKIN059912 | p-cresol | C7H8O | 108.14 g/mol | CC1=CC=C(C=C1)O | |
| TCMBANKIN059914 | alpha-terpinene | C10H16 | 136.23 | CC1=CC=C(CC1)C(C)C | |
| TCMBANKIN059916 | 2,6,6-trimethyl-2,4-cycloheptadien-1-one | C10H14O | 150.22 | CC1=CC=CC(CC1=O)(C)C | |
| TCMBANKIN059921 | o- Cymene | C10H14 | 134.22 g/mol | CC1=CC=CC=C1C(C)C | |
| TCMBANKIN059963 | naphthalene,1,2,3,5,6,8a-hexahydro-4,7-dimethyl-1-(1-methylethyl)-,(1S-cis)-;Naphthalene, 1, 2, 3, 5, 6, 8a-hexahydro-4, 7-dimethyl-1-(1-methylethyl)-,(1S-cis);δ-cadinol | C15H24;C10H18 | 204.35 g/mol | CC1=CC2C(CCC(=C2CC1)C)C(C)C | |
| TCMBANKIN059970 | 1, 4-Cyclohexadiene, 1-methyl-4-(1-methylethyl);crithmene;4-Isopropyl-1-methyl-1,4-cyclohexadiene;Moslene;gamma-terpinene | C10H16 | 136.23 g/mol | CC1=CCC(=CC1)C(C)C | |
| TCMBANKIN060009 | copaene; (-)-Alpha-Copaene; α-copaene | C15H24 | 204.35 g/mol | CC1=CCC2C3C1C2(CCC3C(C)C)C | |
| TCMBANKIN060460 | b-Cubebene | C15H24 | 204.35 g/mol | CC1CCC(C2C13C2C(=C)CC3)C(C)C | |
| TCMBANKIN060735 | EB | C8H10 | 106.16 g/mol | CCC1=CC=CC=C1 | |
| TCMBANKIN060849 | (±)-erythro-1-(1-oxo-4,5-dihydroxy-2 e-decaenyl)piperidine | CCCCCC(C(C=CC(=O)N1CCCCC1)O)O | |||
| TCMBANKIN060863 | sarmentine | C14H23NO | 221.34 g/mol | CCCCCC=CC=CC(=O)N1CCCC1 | |
| TCMBANKIN060864 | N-isobutyl-decatrans-2-trans-4-dienamide | C14H25NO | 223.35 g/mol | CCCCCC=CC=CC(=O)NCC(C)C | |
| TCMBANKIN060888 | caproaldehyde | C6H12O | 100.16 g/mol | CCCCCC=O | |
| TCMBANKIN060933 | 2,4-dodecadienoic acid pyrrolidide | C16H27NO | 249.39 | CCCCCCCC=CC=CC(=O)N1CCCC1 | |
| TCMBANKIN060944 | nonanoic acid | C9H18O2 | 158.24 g/mol | CCCCCCCCC(=O)O | |
| TCMBANKIN060958 | oleic acid;cis-oleic acid;oleinic acid | C18H34O2 | 282.46 | CCCCCCCCC=CCCCCCCCC(=O)O | |
| TCMBANKIN061006 | lauric acid | C12H24O2 | 200.32 | CCCCCCCCCCCC(=O)O | |
| TCMBANKIN061029 | myristic acid | C14H28O2 | 228.37 | CCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN061043 | MYS | C15H32 | 212.41 | CCCCCCCCCCCCCCC | |
| TCMBANKIN061085 | n-heptadecane;heptadecane;Heptadekan | C17H36 | 240.5 g/mol | CCCCCCCCCCCCCCCCC | |
| TCMBANKIN061090 | n-octadecane;Oktadekan;octadecane | C18H38 | 254.49g/mol | CCCCCCCCCCCCCCCCCC | |
| TCMBANKIN061102 | LFA | C20H42 | 282.55 g/mol | CCCCCCCCCCCCCCCCCCCC | |
| TCMBANKIN061574 | feruloyltyramine | n- cis-feruloyltyramine; NP-001984; (E)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; NCGC00169550-01; N-Trans-Feruloyl Tyramine; Moupinamide, >=95% (LC/MS-ELSD); 66648-43-9; Alfrutamide; trans-N-Feruloyltyramine; (E)-3-(4-Hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxy-phenyl)-ethyl]-acrylamide; N-Feruloyltyramine; ZINC901461; MEGxp0_000693; Feruloyltyramine; Moupinamide; BRD-K98045316-001-01-0; MolPort-001-740-847; 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)ethyl)-; MCULE-4768764740; n-trans-feruloyl-tyramine; W1092; (2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; ACon1_001233; N-trans-Feruloyltyramine; (2,3)trans-N-(p-Hydroxyphenethyl)ferulamide; CHEMBL206555; 65646-26-6; n- trans-feruloyltyramine; N-Transferuloyl Tyramine; MFCD17214811; AKOS025287596; CHEBI:17818; C02717; AC1NQX6M; (E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; CHEBI:17818; 3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; AIDS113439; (2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; 3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (2,3)trans-N-(p-Hydroxyphenethyl)ferulamide; N-trans-Feruloyltyramine; C02717; (E)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]acrylamide; 3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]acrylamide; N-Feruloyltyramine; 65646-26-6; (E)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; AIDS-113439; 66648-43-9; Feruloyltyramine; moupinamide; 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)ethyl)-; ACon1_001233; (E)-3-(4-Hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxy-phenyl)-ethyl]-acrylamide; MEGxp0_000693; 2-Propenamide, 3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)ethyl)-, (2Z)-; 80510-09-4; (Z)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (Z)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide; (Z)-3-(4-hydroxy-3-methoxy-phenyl)-N-[2-(4-hydroxyphenyl)ethyl]acrylamide; Moupinamide; n-trans-feruloyltyramine; N-E-feruloyl tyramine; n-cis-feruloyltyramine | C18H19NO4 | 313.3 g/mol | COC1=C(C=CC(=C1)C=CC(=O)NCCC2=CC=C(C=C2)O)O |
| TCMBANKIN061771 | piplartine | Prestwick_399; 1-[3-(3,4,5-Trimethoxy-phenyl)-acryloyl]-5,6-dihydro-1H-pyridin-2-one; 5,6-Dihydro-1-(3,4,5-trimethoxycinnamoyl)-2(1H)-pyridone; MolPort-001-741-398; CHEMBL465843; HMS2096J10; J-012992; BPBio1_000560; NCGC00096028-01; CHEBI:8241; BRD-K24132293-001-05-3; BRD-K24132293-001-09-5; AM-730/20761034; ZB015157; (E)-1-[3-(3,4,5-Trimethoxyphenyl)acryloyl]-5,6-dihydropyridin-2(1H)-one; AC1LCV4N; 2659AH; (E)-1-(3-(3,4,5-trimethoxyphenyl)acryloyl)-5,6-dihydropyridin-2(1H)-one; PPLGM; SCHEMBL2465593; (2E)-1-(1,2,5,6-Tetrahydro-2-oxopyridine-1-yl)-3-(3,4,5-trimethoxyphenyl)-2-propene-1-one; CCG-214375; Prestwick2_000604; Piperlongumine; BRD2293; 5,6-Dihydro-1-(1-oxo-3-[3,4,5-trimethoxyphenyl]-trans-2-propenyl)-2[1H]-pyridinone; SGD66V4SVJ; ZINC899053; NCGC00096028-03; 5,6-Dihydro-1-(3,4,5-trimethoxycinnamoyl)-2(1H)-pyridinone; MFCD00075706; 20069-09-4; C10166; SCHEMBL173092; BRD-K24132293-001-16-0; (E)-5,6-Dihydro-1-[1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl]-2(1H)-pyridinone; Prop-2-en-1-one, 3-(3,4,5-trimethoxyphenyl)-1-(2,3-dihydropyridin-6(1H)-one-1-yl)-; Piplartin; 2(1H)-Pyridinone,5,6-dihydro-1-[(2E)-1-oxo- 3-(3,4,5-trimethoxyphenyl)-2-propenyl]-; A1-00162; HMS1569J10; VABYUUZNAVQNPG-BQYQJAHWSA-N; 5,6-Dihydro-1-[1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl]-2(1H)-pyridinone, 9CI; 2(1H)-Pyridinone, 5,6-dihydro-1-(1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)-, (E)-; SR-01000841248; ACon1_001541; UNII-SGD66V4SVJ; Prestwick3_000604; BSPBio_000508; HMS2234K24; 1-[(2E)-3-(3,4,5-Trimethoxyphenyl)-2-propenoyl]-5,6-dihydro-2(1H)-pyridinone #; BRD-2293; 5,6-Dihydro-1-[1-oxo-3-(3,4,5-trimethoxyphenyl)-trans-2-propenyl]-2(1H)-pyridinone; NCGC00096028-04; SMR001233252; MLS002153903; N-(3,4,5-Trimethoxycinnamoyl)-D3-piperidin-2-one; P2361; 1-[(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]-1,5,6-trihydropyridin-2-one; Piperlongumin; ST079382; CHEBI:92424; 1-[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]-2,3-dihydropyridin-6-one; AKOS024284776; NCGC00096028-02; Piperlongumine, >=97% (HPLC); C-54604; s7551; 1-[(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]-1,2,5,6-tetrahydropyridin-2-one; AK326371; 5,6-Dihydro-1-[(2E)-1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propen-1-yl]-2(1H)-pyridinone; SR-01000841248-2; Piplartine; 4CN-2875; SPECTRUM1505135; piperlongumine | C17H19NO5 | 317.34 g/mol | COC1=CC(=CC(=C1OC)OC)C=CC(=O)N2CCC=CC2=O |
| TCMBANKIN061822 | 4-methoxybenzaldehyde | KS-000002NI; EC 204-602-6; anisaldehyd; 4-methoxylbenzaldehyde; SBB040224; FEMA No. 2670; DB-012818; 4-Methoxybenzaldehyde; 4-(methyloxy)benzaldehyde; A0480; MFCD00003385; CJ-01596; SC-26765; 4-Methoxybenzaldehyde, 98% 50g; bmse010130; AK-72956; BENZALDEHYDE,4-METHOXY MFC8 H8 O2; 4-methoxybenzoyl; 4-Anisaldehyde; NCGC00257076-01; AN-22903; EBD1062; I922; P-ANISALDEHYDE; p-Anisic aldehyde; p-Methoxybenzaldehyde; Anisaldehyde; anisal; 79582-EP2305698A2; 4-methoxybenzaldehye; BG01497623; C10761; EINECS 256-891-3; DSSTox_RID_78277; Methoxybenzaldehyde (Related); EINECS 204-602-6; KB-193002; BB_NC-2206; AS02988; NSC 5590; p-Anisaldehyde, natural, 98%, FG; Benzaldehyde, 4-methoxy-; 4-Methoxy-benzaldehyde; HMS3039F08; p-Methoxybenzylidenemalonitrile; DSSTox_GSID_26997; 4-methoxybenzene carboxaldehyde; I01-0482; 123-11-5; anisic aldehyde (natural); UNII-9PA5V6656V; RP20260; AJ-14902; p-Anisaldehyde, United States Pharmacopeia (USP) Reference Standard; Q-100105; 79582-EP2292628A2; ST50213373; Anisaldehyde solution; 79582-EP2374783A1; DTXSID2026997; p-Methoxy Benzaldehyde, Natural; NCGC00090807-01; KB-115367; ZINC157146; p-Anisaldehyde, primary pharmaceutical reference standard; AI3-00223; 68894-36-0; 79582-EP2298755A1; AC-10379; AC1L1L81; CHEMBL161598; p-Anisaldehyde, for synthesis, 98.0%; 4-methoxy-benzaldehyde; LS-20018; 29578-EP2308838A1; CAS-123-11-5; SCHEMBL1100; 29578-EP2311825A1; InChI=1/C8H8O2/c1-10-8-4-2-7(6-9)3-5-8/h2-6H,1H; SMR001224521; p-Anisaldehyde, 8CI; 29578-EP2305696A2; 4-08-00-00252 (Beilstein Handbook Reference); LS-2093; 79582-EP2305695A2; para-methoxybenzaldehyde; 26249-15-0; ZRSNZINYAWTAHE-UHFFFAOYSA-N; CHEBI:28235; NATURAL ANISIC ALDEHYDE; DSSTox_CID_6997; p-Formylanisole; Anisaldehyde; p-Anisaldehyde (4-Methoxybenzaldehyde); ACMC-1BAZN; 29578-EP2305695A2; Formylanisole, p-; WLN: VHR DO1; p-Anisaldehyde, 98%; p-Methoxybenzafdehyde; BRN 0471382; ZB006571; Caswell No. 051E; ST2411506; FT-0617622; 4-Methoxybenzaldhyde; p-Anisaldehyde, certified reference material, TraceCERT(R); KSC174M6D; 29578-EP2311842A2; NCGC00259492-01; p-Methoxybenzaldehyde (natural); p-Anisaldehyde, >=97.5%, FCC, FG; p-Methoxybenzaldehyde; Tox21_303331; 721942-53-6; p-Anisic aldehyde; 3-Chlorobenzenesulfonyl chloride, 98%; 79582-EP2305696A2; MLS002152921; RTR-003659; A805017; p-Anisaldehyde, analytical standard; 4-methoxy benzaldehyde; Anis aldehyde; para-anisaldehyde; 4-methoxybezaldehyde; HSDB 2641; 29578-EP2284160A1; PubChem22535; Aubepine; 29578-EP2305698A2; Jsp001555; I01-8766; ANW-18100; 79582-EP2305697A2; AKOS000118814; 29578-EP2292628A2; M-6033; Anisic aldehyde; CTK0H4661; BR-72956; TR-003659; TRA0080347; 79582-EP2287153A1; BBL027436; Tox21_201943; NCGC00090807-02; NSC-5590; para-methoxy benzaldehyde; Obepin; CCG-214805; MolPort-000-871-198; CS-W020189; FEMA 2670; Anisaldehyde (para); 79582-EP2377841A1; 29578-EP2305697A2; MCULE-9537754812; F2190-0575; 9PA5V6656V; p-methoxy benzaldehyde; AC1Q4CCF; NSC5590; CCRIS 821; BDBM50139370; Crategine;anisaldehyde;p-Anis aldehyde;AI3-00223; 4-Anisaldehyde; Crategine; 26249-15-0; p-Methoxybenzaldehyde (natural); EINECS 204-602-6; C10761; 19486-71-6; 68894-36-0; NSC 5590; 4-Methoxybenzaldehyde-; CCRIS 821; Aubepine; ZINC00157146; InChI=1/C8H8O2/c1-10-8-4-2-7(6-9)3-5-8/h2-6H,1H; WLN: VHR DO1; Anisaldehyde solution; (4-METHOXYPHENYL)((2)H)FORMALDEHYDE; Benzaldehyde, 4-methoxy-; Benzaldehyde, methoxy-; ST5213373; p-Formylanisole; W267007_ALDRICH; HSDB 2641; A-d1; 4-08-00-00252 (Beilstein Handbook Reference); deuterio-(4-methoxyphenyl)methanone; Obepin; p-Anisaldehyde; Aub+ pine; NSC5590; ANISALDEHYDE; 4-Methoxybenzaldehyde; 97063_FLUKA; 123-11-5; FEMA No. 2670; p-Anisic aldehyde; Caswell No. 051E; BRN 0471382; 50984-52-6; DTXSID40460063; A88107_ALDRICH; 4-Methoxybenzaldehyde-alpha-d1, 98 atom % D; 4-Methoxybenzaldehyde-alpha-d1; p-Methoxybenzaldehyde; Formylanisole, p-; BENZALDEHYDE,4-METHOXY MFC8 H8 O2; LS-2093; Anisic aldehyde; EINECS 256-891-3; NCGC00090807-01; Methoxybenzaldehyde; SRA1_SIAL; p-Anisaldehyde-;p-anisaldehyde | C8H8O2 | 136.15 g/mol | COC1=CC=C(C=C1)C=O |
| TCMBANKIN061849 | 1-methoxy-4-(2-propenyl)-benzene | 4-Allylanisole;estragole;esdragol;Terragon;methylchavicol;CCRIS 1317; MolPort-000-156-967; MFCD00008653; Estragol (methylchavicol); DSSTox_CID_575; Anisole, p-allyl-; Esdragol; 1-allyl-4-methoxy-benzene; DTXSID0020575; 4-allylanisol; Methyl chavicole (estragole); p-Methoxyallylbenzene; Benzene, 1-methoxy-4-(2-propen-1-yl)-; NCGC00091434-01; chavicyl methylether; CTK7A3557; Methyl chavicole; UNII-9NIW07V3ET; Estragol; SR-01000838348; 4-06-00-03817 (Beilstein Handbook Reference); Ether, p-allylphenyl methyl; NSC 404113; Tarragon; 140-67-0; DSSTox_RID_75667; O080; Chavicol methyl ether; Benzene, 1-methoxy, 4-prop-2-enyl; AK109291; FEMA No. 2411; p-Allylphenyl methyl ether; p-allylanisole, 4-allyl-1-methoxybenzene, methyl chavicol; Chavicol, O-methyl-; NSC-404113; CHEMBL470671; CCG-214642; 4-Allylanisole, analytical standard; FEMA 2411; 1-METHOXY-4-(2-PROPENYL)BENZENE; FEMA Number 2411; EPA Pesticide Chemical Code 062150; 4-Allylmethoxybenzene; Benzene, 1-methoxy-4-(2-propenyl)-; HMS2268E24; SMR000112379; p-Allylanisole; SPECTRUM1505117; 1-methoxy-4-(prop-2-en-1-yl)benzene; Chavicyl methyl ether; chavicol methylether; C10452; NCI-C60946; Allylphenyl methyl ether, p-; estragon;p-allylanisole; EINECS 205-427-8; AI3-16052; Esteragol; ZINC967635; 4-Allylanisole, purum, >=97.0% (GC); CHEBI:4867; 1407-27-8; Estragole (natural); NCGC00259936-01; MLS001065575; 1-methoxy-4-prop-2-enylbenzene; Methyl chavicol; AC1Q4FE9; 1-Methoxy-4-(2-propen-1-yl)-Benzene; Methylchavicol; Chavicol, methyl-; p-Allyl-Anisole; ACMC-1BW75; KB-36193; 3-(p-Methoxyphenyl)propene; 1-methoxy-4-(2-propenyl)-benzene; InChI=1/C10H12O/c1-3-4-9-5-7-10(11-2)8-6-9/h3,5-8H,1,4H2,2H; AKOS000121300; p-Allylmethoxybenzene; Methyl-Chavicol; AC1L1RR7; Tox21_302930; 3-(4-Methoxyphenyl)-1-propene; ST50824126; BRN 1099454; Isoanthethole; LS-821; Esdragon; ZFMSMUAANRJZFM-UHFFFAOYSA-N; I01-10181; Estragole, analytical standard; 9NIW07V3ET; O-Methyl-Chavicol; Terragon; 4-Allyl-1-methoxybenzene; BENZENE,1-ALLYL,4-METHOXY METHYLCHAVICOL; HSDB 5412; 4-Allylanisole, 98%; Chavicyl methyl ether; AN-17349; 1-Methoxy-4-(2-propenyl)benzene, 9CI; A0702; 4-Allylanisole; para-allylanisole; AC1Q4CFH; SCHEMBL57204; WLN: 1U2R DO1; SR-01000838348-2; FT-0617414; J-007415; NCGC00091434-02; TC-109325; CAS-140-67-0; isoanethole, 4-Allylanisole; ANW-20580; 4-Methoxyallylbenzene; Tox21_202387; Estragole; NSC404113; Esdragole; 77525-18-9; AJ-24538; DSSTox_GSID_20575; NCGC00091434-03; Para-allylanisole (estragole); ZB015470; BENZENE,1-ALLYL,4-METHOXY METHYLCHAVICOL; 1-Allyl-4-methoxybenzene; NCGC00256481-01; 4-Allylanisole, >=98%, FCC; 1-Methoxy-4-(2-propen-1-yl)benzene; Isoanethole;34098_RIEDEL; 3-(p-Methoxyphenyl)propene; InChI=1/C10H12O/c1-3-4-9-5-7-10(11-2)8-6-9/h3,5-8H,1,4H2,2H; 1-METHOXY-4-(2-PROPENYL)BENZENE; Anisole, p-allyl-; EPA Pesticide Chemical Code 062150; 1-allyl-4-methoxy-benzene; Esdragol; FEMA Number 2411; p-Allylmethoxybenzene; NCGC00091434-02; 4-Allylmethoxybenzene; Benzene, 1-methoxy-4-(2-propenyl)-; p-Methoxyallylbenzene; 4-Methoxyallylbenzene; BRN 1099454; WLN: 1U2R DO1; SPECTRUM1505117; p-Allylanisole; LS-821; Esdragon; NCGC00091434-01; Estragol; Chavicyl methyl ether; C10452; Estragole; 4-06-00-03817 (Beilstein Handbook Reference); NSC404113; Esdragole; NCI-C60946; NSC 404113; 77525-18-9; 4-Allyl-1-methoxybenzene; Tarragon; 140-67-0; Allylphenyl methyl ether, p-; HSDB 5412; EINECS 205-427-8; ZINC00967635; AI3-16052; Isoanethole; 1-methoxy-4-prop-2-enyl-benzene; A29208_ALDRICH; 05820_FLUKA; Chavicol methyl ether; 05818_FLUKA; BENZENE,1-ALLYL,4-METHOXY METHYLCHAVICOL; 1407-27-8; W241105_ALDRICH; Estragole (natural); 1-Allyl-4-methoxybenzene; FEMA No. 2411; 4-Allylanisole; 1-Methoxy-4-(2-propen-1-yl)benzene; Chavicol, O-methyl-; 1-methoxy-4-prop-2-enylbenzene; Methyl chavicol; Methylchavicol | C10H12O | 148.2 g/mol | COC1=CC=C(C=C1)CC=C |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab